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Aim: To develop an antigen detection test that would quickly exclude H. ducreyi infection in 
individuals with genital ulcers. 
Materials and Methods: H. ducreyi strains A54 and A68 were grown on Modified Bieling 
(MB) agar plates and in MB broth under microaerophilic conditions. The 58.5 kDa GroEL 
Heat Shock Protein (HSP) was extracted from H. ducreyi strain A54 by means of sonication. 
The purified HSP was used to raise antibodies in rabbits. HSP determination and separation 
was done on SDS PAGE gels and protein was eluted by means of a passive elution process. 
Antibody was purified by affinity chromatography and a fraction of the antibody was 
conjugated to a chromogen to be used as a detection antibody. An ELISA was developed to 
evaluate the antibody response to the HSP. A second ELISA was developed to evaluate test 
parameters. 
Results: A good immune response was achieved with the crude serum of one of the three 
rabbits when tested against the antigen by means of ELISA. However, after purification of the 
IgG from the serum of the same rabbit no antigen-antibody binding was observed. Anti-rabbit 
IgG was able to recognise the antibodies.   
Discussion and Conclusion: While the Fc portion of the purified IgG remained active, the 
Fab portion of the antibody had lost biological activity. This loss of biological activity of 
antibody can be attributed to the low pH of the elution buffers used during the purification 
steps. Alternative antibody purification systems need to be explored. The use of monoclonal 
antibodies also needs to be considered. 
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Chapter One: Introduction 
 
Chancroid was once a prevalent disease found in many parts of Africa, Asia and Latin 
America (Trees and Morse, 1995). At the onset of the 20th century the occurrence of chancroid 
began to decline (Steen, 2001). The true incidence of chancroid is not entirely known due to 
incomplete reporting of such infections as clinical differentiation of chancroid from other 
forms of genital ulcer disease is almost impossible (Morse, 1989). In addition, there is a “lack 
of availability of diagnostic tests, especially in the resource-poor countries in which chancroid 
is most prevalent” (Al-Tawfiq and Spinola, 2002).  
 
Epidemics of the disease have been shown to be associated with prostitution (Steen, 2001; 
O’Farrell, 2000), despite the fact that the prevalence in men is much higher than in women 
with reported male: female ratios ranging from 3:1 and 25:1 (Morse, 1989).  
 
As emphasised previously by Vuylsteke (2004), the development of simple, cheap and rapid 
diagnostic tests for STIs “may represent an important break-through for STI control in 
symptomatic and asymptomatic women in developing countries” (Vuylsteke, 2004). In 
addition, if results are obtained rapidly, treatment accordingly based on syndromic 
management guidelines can be replaced by targeted treatment. As in other African countries, 
in South Africa the prevalence of chancroid among patients with genital ulcer disease has over 
the last 10 years decreased to less than 1 %. Despite this, all patients diagnosed with this 
syndrome are treated for chancroid. Therefore, the most important contribution of a rapid 
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point-of-care test to patient management would be the avoidance of the use of anti-chancroid 
drugs in patients with a negative test. 
 
This study focused on the 58.5 kDa GroEL Heat Shock Protein (HSP) which is produced in 
abundance by the causative agent of chancroid, the bacterium Haemophilus ducreyi. HSPs are 
highly conserved (Parsons et al, 1992) and are produced when bacteria encounter different 
types of stresses such as heat, anoxia, heavy metal ions and ethanol (Lindquist and Craig, 
1988). Brown et al (1993) already has successfully developed a monoclonal antibody, BB11 
to this HSP (Brown et al, 1993). 
 
In this study, we aimed to develop a rapid test that would quickly exclude the possibility of 










Chapter Two: Review of Literature 
 
2.1 Historical Background: 
Haemophilus ducreyi is a Gram negative bacterium and is the causative agent of chancroid 
which is a genital ulcer disease (GUD) (Morse, 1989). H. ducreyi is a fastidious organism 
(Albritton, 1989; Morse, 1989) which is problematic to culture (Trees and Morse, 1995; 
Hammond et al, 1996; Steen, 2001), especially from clinical specimens (Hammond et al, 
1978; Trees and Morse, 1995). 
  
Chancroid is a venereal disease which is characterized by ulceration and is often accompanied 
by painful tender inguinal lymphadenopathy. In some cases the swollen lymph nodes develop 
into buboes (Morse, 1989). Chancroid or soft chancre was described in 1852 by Leon 
Bassereau who was the first to differentiate the infection from hard indurated chancre of 
primary syphilis (as cited by Morse, 1989; Hammond, 1996; Lewisa, 2000). Bassereau had 
demonstrated this by reinfecting soft chancre patients at different skin sites by autoinoculation 
with purulent material from the patient’s own ulcers (as cited by Morse, 1989).  
 
In 1889, Augusto Ducrey had reported his findings which had led to the identification of the 
causative agent for chancroid, hence the name H. ducreyi in recognition of Ducrey’s findings 
(as cited by Lewisa, 2000). Ducrey had described H. ducreyi as being short streptobacillary 
rods with rounded ends (as cited by Morse, 1989).  
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Even though controversy exists over the first in vitro culture isolation of Haemophilus ducreyi, 
credit is generally given to Lenglet for successfully isolating H. ducreyi in 1898 (as cited by 
Morse, 1989; Lewisa, 2000) and Bezancon in the 1900s (as cited by Morse, 1989). Bezancon 
et al (1900) had fulfilled Kock’s postulates by identifying H. ducreyi as the microbe 
responsible for chancroid. He demonstrated this by inoculating the forearms of human 
volunteers with purified culture of the suspected microbes. The volunteers developed ulcers 
which were characteristic of chancroid. He was able to reisolate H. ducreyi from the resulting 
lesions and thus fulfilled Kock’s postulates (as cited by Lewisa, 2000). 
 
2.2 Taxonomic Position 
“The genus Haemophilus was established with the preliminary report of the Committee of the 
Society of American Bacteriologists on Characterization of Bacterial Types” (Albritton, 
1989). 
 
Bergey’s Manual of Systematic Bacteriology places bacteria in the genus Haemophilus 
according to its growth requirements for particular components. A gram-negative rod or 
coccobacillus would be placed within the genus Haemophilus if these microorganisms shared 
a requirement for either hemin (factor X), nicotinamide adenine dinucleotide (NAD) (factor 
V) or both. If these factors are not required for the microorganism’s growth then the 




Bezancon’s work in the 1900s has been credited for being the first to culture H. ducreyi on 
blood containing media. His work is said to be of significance because he was able to show 
that cultures grown on blood agar after serial passage were still able to produce ulcers when 
reinoculated into humans (as cited by Albritton, 1989). It was this requirement of blood for 
growth which led the genus Haemophilus to be included in the first edition of Bergey’s 
Manual (Morse, 1989). 
 
It has been reported that doubts may be raised as to the proper classification of a bacterium 
when belonging to the genus Haemophilus if its guanine-plus-cytosine (G+C) content lies 
outside the range of 37 to 44 mol % (midpoint temperature), even if the organism in question 
possesses typical growth requirements for factors X or V (Morse, 1989). In the case of 
H. ducreyi, all conditions regarding ‘G+C content’ and ‘common growth requirements’ seem 
to be satisfied, as H. ducreyi is a gram-negative rod or coccobacillus which has a G+C content 
of 38 mol % (midpoint temperature) and a growth requirement for hemin (factor X) (Morse, 
1989).  
 
The criteria used above which confines the genus Haemophilus by its growth factor 
requirements has since been challenged by DNA homology studies (Morse, 1989; Bergey’s 
Manual of Systematic Bacteriology, 1984). An example of such a study includes findings that 
H. ducreyi have the isoprenoid structure type of demethylmenaquinone and menaquinone 
which signifies a physiological and chemotaxomic difference between other Haemophilus 
species and H. ducreyi. Therefore this data fails to support H. ducreyi’s inclusion into the 
genus Haemophilus (Carlone et al, 1988). In addition, it has been documented that the 
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presence of menaquiones within the Pasteurellaceae family to which Haemophilus species 
belong is also an unusual occurrence (Albritton, 1989). 
 
According to Albritton (1989), in terms of classification, H. ducreyi appears to be a 
monospecies genus, genetically distant but sharing numerous morphological, structural and 
metabolic characteristics with members of the family Pasteurellaceae (Albritton, 1989). In 
2003, the full genome sequencing of the species was performed (Munson et al, 2003). This 
confirmed its distant relationship with other organisms in the genus Haemophilus.  
 
2.3 Epidemiology 
Chancroid (or soft chancre) is a sexually transmitted disease (STD) which was once common 
in Africa, Asia and Latin America (Trees and Morse, 1995; Lewisa, 2000). Although 
chancroid has been distributed throughout the world, it remains uncommon in the United 
States (Trees and Morse, 1995; Lewisa, 2000) and Western Europe (Lewisa, 2000). The true 
global incidence of chancroid is not known as specific diagnosis is difficult (Morse, 1989) due 
to the lack of available diagnostic tests, especially in poorer countries where the prevalence of 
chancroid is much higher (Al-Tawfiq and Spinola, 2002). Disease transmission may be 
associated with prostitution (Steen, 2001; O’Farrell, 2000; Mohammed and Olumide, 2008), 
drug abuse (O’Farrell, 2000, Mohammed and Olumide, 2008), alcohol (Mohammed and 
Olumide, 2008), syphilis (O’Farrell, 2000), an increased risk of HIV infection (O’Farrell, 
2000) and poor hygiene; as topical hygiene was shown to be effective in reducing H. ducreyi 
transmission (Steen, 2001). Chancroid is more common in male as compared to female with 
reported male/female ratios ranging from 3:1 to 25:1 (Morse, 1989).  
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According to the Centers for Disease Control and Prevention (CDC, Sexually transmitted 
disease treatment guidelines, 2006), chancroid in the United States (US) usually presents as 
discrete outbreaks but in some areas it may still be endemic. Approximately 10% of persons 
who are infected with chancroid in the United States are said to be co infected with HSV or 
T. pallidum. As compared to outside the US, the above percentage was reported to be higher in 
persons who were infected with chancroid (CDC, Sexually Transmitted Disease Treatment 
Guidelines, 2006). In the last several years leading up to the early 21st century, the reported 
number of cases within the United Kingdom has not reached epidemic proportions (O’Farrell, 
2000).  
 
H. ducreyi infectivity occurs within a short time frame and therefore can spread within a 
population by means of frequent person to person contact as a result of sexual activity. Since 
H. ducreyi is a human pathogen, their survival would depend on an adequate turnover of sex 
partners (around 15 to 20 sex partners per year) within sub-groups of the population (Steen, 
2001).  
 
In the 19th and early 20th centuries, chancroid which was once a prevalent disease had 
suddenly taken a different course. It was during the 20th century that evidence began to show 
signs of the disease declining (Steen, 2001). In 1908, the United States (US) army reported 
that chancroid which was once more prevalent than syphilis, began to decline at a faster rate 
than syphilis between 1908 and 1930. Furthermore, between 1947 and 1997, chancroid in the 
US showed a decrease by more than 80-fold (Steen, 2001). This declining rate of chancroid 
continued and in 1999 (figure 2.1), the US reported a total of 143 cases of chancroid with only 
sixteen states and one outlying area reporting one or more chancroid cases. Three states 
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reported nearly 72% of the 143 cases (CDC, Sexually Transmitted Disease Surveillance 
Report, 1999). In the US, the decline of chancroid is evident with the more recent statistics 
with reports of only 25 chancroid cases nationwide in 2008 (CDC, Sexually Transmitted 




Figure 2.1: Chancroid – reported cases in the United States from 1961 to 1999. 
 
A sentinel study done in South Africa had reported on a significant decline in the number of 
ulcers attributed to chancroid (Johnson et al, 2005). In Durban, data on the aetiology of genital 
ulcer disease have been collected since 1984. These showed a decline in chancroid prevalence 
from more than 50 % in 1995 to < 1 % in 2004 (personal communication: Prof A.W. Sturm).  
 
In West Africa, chancroid was found to be less common but disease transmission could still be 
maintained by importation from other regions (Steen, 2001). A decline in chancroid 
9 
prevalence has also been observed in countries such as the Philippines, Senegal and Thailand, 
an occurrence that may aid in stabilizing the HIV epidemics in these countries (Steen, 2001). 
It is likely that several factors may have played a role in wiping out chancroid as an endemic 
disease in developed western civilization. This scarcity of chancroid began to unfold in Europe 
and North America even earlier than the discovery of sulfa drugs and penicillin (Steen, 2001).  
Nevertheless, credit is given to several classes of antibiotics, some of which are administered 
in single-dose therapy which provides a rapid cure and may as well have contributed to the 
decline of chancroid infections (Steen, 2001). 
 
Steen (2001), reports that the early decline of chancroid is likely to be accredited to the social 
changes and varying patterns of commercial sex work (Steen, 2001), which perhaps 
interrupted the conditions needed to maintain chancroid epidemics.  
 
2.4 Acquisition of H. ducreyi infection 
Humans are the natural host for H. ducreyi infection where these microorganisms infect 
genital and nongenital skin, stratified squamous epithelium, mucosal surfaces and regional 
lymph nodes, resulting in the development of painful ulcerations (Spinola et al, 2002; Bong et 
al, 2002). H. ducreyi is thought to gain entry into the skin by means of superficial micro 
abrasions that may occur during sexual intercourse (Spinola et al, 2002).  
 
Not much is known about the initial stages of natural occurring infection as patients tend to 
seek medical treatment at the ulcerative stage of infection (Bauer and Spinola, 2000; Spinola 
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et al, 2002). It is for this reason that experimental infection of humans are carried out to 
provide information on the initial stages of infection (Bong et al, 2002).  
 
Human models of H. ducreyi infection have been developed to better understand the 
pathogenesis of chancroid (Bauer and Spinola, 2000; Bauer et al 2001; Bong et al, 2002).  The 
human model of H. ducreyi infection basically involves the inoculation of human volunteers in 
the upper arm, namely the dermis and epidermis (Bong et al, 2002; Spinola et al, 2002) with 
H. ducreyi via puncture wounds which are performed with an allergy-testing device (Bong et 
al, 2002). The human model incorporates characteristics of a low estimated delivered dose 
(EDD) of H. ducreyi and shows the dynamics of papule and pustule formation resembling the 
early stages of chancroid, accompanied by a cutaneous infiltrate of polymorphonuclear (PMN) 
and mononuclear cells that imitate the histopathology of natural ulcers (Bauer and Spinola, 
2000). To ensure the safety of the volunteers involved, infection is terminated when a 
volunteer has a painful pustule or ulcer or until 14 days of infection (Bauer and Spinola, 2000; 
Spinola et al, 2002).  
 
Bauer and Spinola (2000) developed an immunodetection assay which was used to localize 
H. ducreyi within biopsy specimens obtained from the human model of H. ducreyi infection. 
The bacteria were not found to be associated with keratinocytes. They found H. ducreyi to be 
associated with neutrophils during the pustular stage of disease (Bauer and Spinola, 2000). 
Bauer and Spinola (2000) attributed this work as being the first localization study of 
H. ducreyi in chancroid (Bauer and Spinola, 2000). In 2001, Bauer et al (2001) reported on the 
localization of H. ducreyi cells in tissue of human volunteers at 0, 24 and 48 hours after 
inoculation and at the clinical end point. By 48 hours of infection, H. ducreyi was reported to 
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be present in the pustules and dermis. The bacteria had co-localized primarily with 
macrophages, PMNs, fibrin and collagen. No association was observed with other eukaryotic 
components. These findings suggest that fibrin and collagen may be important targets of 
adherence in vivo and that the extracellular localization of H. ducreyi during the pustular stage 
of infection could possibly be a means to avoid phagocytic killing, thus ensuring their survival 
(Bauer et al, 2001). To further understand the pathogenesis of H. ducreyi and its interactions 
with tissue components, Bauer et al (2006), had extended their work by investigating the in 
vivo localization of H. ducreyi at the ulcerative stage of disease and compared the findings 
with experimental infection. They showed that H. ducreyi co-localized with neutrophils and 
fibrin during the ulcerative stage, and no H. ducreyi was found to be associated with 
keratinocytes, fibroblasts and collagen. This report was the first to localize H. ducreyi in 




2.5 Colony Morphology 
Colonies of H. ducreyi on solid medium are 0.5 mm in size at 24 hours and can increase to 1 
or 2 mm within 48 to 72 hours (Morse, 1989). According to Sturm and Zanen (1984), colonies 
have a polymorphic appearance (Sturm and Zanen, 1984). In general, they are small, non 
mucoid, with a yellowish or grey colour (Albritton, 1989; Morse, 1989), as well as compact 
and granular (Morse, 1989). They can be translucent, opaque and semiopaque (Morse, 1989). 
Colony characteristics may vary depending on the type of growth medium and incubation 
period (Morse, 1989).  
 
A characteristic observation of H. ducreyi colonies is that, when pushed across the surface of 
solid medium with an inoculating loop, colonies should glide easily and remain intact (Sturm 
and Zanen, 1984; Morse, 1989). This characteristic can be explained by the intercellular 
adherence of cells which was observed when whole colonies were examined by an electron 
microscope (Morse, 1989). Within the colony there is substantial loss of cell viability. This 
makes single-cell colony isolations very difficult (Albritton, 1989). 
 
2.6 Clinical Features 
H. ducreyi may gain passage into epidermal regions through micro superficial cuts (Morse, 
1989) which may occur during sexual intercourse (Lewisa, 2000; Lewis, 2003). The incubation 
period is short and varies between 4 and 7 days (Morse, 1989; Rosen et al, 2009). The 
incubation period for H. ducreyi is longer in persons who are HIV infected (Mohammed and 
Olumide, 2008; Rosen et al, 2009).  
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A chancroid lesion begins as a small tender papule, surrounded by an erythematous zone. The 
papule rapidly develops into a pustule within 2 or 3 days and eventually erodes to form a 
painful ulcer with soft (in contrast to hard chancre of primary syphilis) ragged undermined 
edges (Morse, 1989, Lewisa, 2000). The infection may lead to the development of a varying 
number of ulcers which are often accompanied by suppurative lymphadenopathy (Spinola et 
al, 2002). Without antibiotic therapy, these ulcers may persist for weeks or months (Lewisa, 
2000), however infection is said to resolve within 3 months (Rosen et al, 2009). The base of 
the ulcer has been described as being irregular with many projections and depressions 
resulting in a granular appearance (Morse, 1989). The lesion is usually filled with yellow-grey, 
foul smelling (Wu et al, 2004; Rosen et al, 2009) necrotic material (Morse, 1989). Chancroid 
ulcers are very vascular and such bleed easily (Morse, 1989). 
 
Several chancroidal ulcers have been previously described (Morse, 1989), these may include: 
1. Giant or serpiginous ulcers (> 2cm) which may develop when several smaller ulcers   
come together.                
2. Follicular type ulcers which develop in a hair follicle (from 1 to > 30) and may 
resemble a folliculitis or pyogenic infection. These superficial ulcers may be common 
on the vulva, labia majora, and in hairy regions. 
3. The so-called dwarf chancroid (0.1 to 0.5 cm) which may appear rounded and shallow. 
Such ulcers can be distinguished by their irregular base and sharp hemorrhagic borders. 
4. Transient chancroid ulcers which may resolve in 4 to 6 days and proceed to acute 
regional lymphadenitis with suppuration in 10 to 20 days. These presentations may be 
difficult to distinguish from lymphogranuloma venereum.  
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5. Papular chancroid develops as a papule and progresses into an ulcer. The lesions are 
described as being raised, particularly around the edges and is said to resemble the 
condylomata latum of secondary syphilis. 
6. Phagedenic chancroid is described as widespread necrotic ulceration with damage of 
genital or perigenital skin (Rosen et al, 2009). 
 
In male patients, chancroid lesions are more likely to appear on the distal prepuce, the inner 
surface of the prepuce on the frenulum (Morse, 1989; Lewisa, 2000; Lewis, 2003) or in the 
coronal sulcus (Morse, 1989). Lesions are less likely seen on the glans, the shaft of the penis, 
or around the anus (Morse, 1989). As a result of local extension, ulcer development may occur 
on the perineum, thigh, scrotum, or lower abdomen (Morse, 1989).  
  
In women, most lesions appear around the opening of the vagina, which may include the 
fourchette, labia, vestibule, and clitoris (Morse, 1989). However, ulcers are also found on the 
cervix and perianal region (Lewisa, 2000). Extra-genital chancroid lesions which are 
uncommon may be present on the inner thighs, breasts, and fingers (Lewis, 2003; Lewisa, 
2000). 
 
At least 50% of chancroid cases have shown the occurrence of painful, tender inguinal 
lymphadenitis and the progression of lymph nodes into buboes (Lewis, 2003).  
Lymphadenopathy is said to be seen more often in men than in women. If not drained by 
means of incision then buboes tend to rupture spontaneously (Lewis, 2003). 
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Existing chancroid ulcers may also lead to autoinoculation of adjacent skin which can result in 
multiple opposing ulcers, also known as ‘kissing ulcers’ (Mohammed and Olumide, 2008; 
Rosen et al, 2009). 
 
2.7 Diagnosis 
The diagnosis of chancroid is based on the detection of Haemophilus ducreyi in genital 
ulcerations or bubo aspirates while excluding the possibility of infection by other genital ulcer 
pathogens (Lewisa, 2000). The clinical presentation of genital ulcer infections with either 
T. pallidum, H. ducreyi and HSV is not a reliable means of diagnosis since clinical 
presentation of these infections can be very similar (Lewisb, 2000). Diagnosis based on 
physical examinations show low sensitivity and specificity for chancroid, primary syphilis, 
and genital herpes (Lewis, 2003). In relation to the primary isolation of H. ducreyi from 
clinical material, Sottnek et al (1980) had faced difficulties in distinguishing H. ducreyi 
colonies from other fastidious organisms such as some Corynebacterium sp, Haemophilus 
parainfluenzae and Haemophilus vaginalis. In this study, six isolates initially thought to be 
pure H. ducreyi culture were later found to be mixed with H. vaginalis (Sottnek et al, 1980). 
Studies like these highlight the difficulties faced and the inaccuracy of prevalence figures of 
chancroid based on diagnosis made by culture and clinical presentation, which was once used 
by older studies as the ‘gold standards’(Lewisb, 2000). Therefore, these diagnostic modalities 
have been replaced by molecular techniques.  
 
The advent of AIDS poses new challenges. Not only is the transmission of the human 
immunodeficiency virus (HIV) facilitated by chancroid (Lewisa, 2000; Wu et al, 2004) but  
16 
concurrent HIV infection could modify the clinical presentation of chancroid (Lewisb, 2000). 
 
2.7.1 Diagnostic techniques: 
2.7.1.1 Microscopy 
The Gram Stain allows for the observation of microscopic features of H. ducreyi. It has been 
established that the average H. ducreyi is a gram negative rod (Morse, 1989) which is 1.2 to 
1.5 µm in length and is approximately 0.5 µm in width with rounded ends (Albritton, 1989). 
Due to the polymicrobial flora found in most clinical smears of genital ulcers the direct 
examination of such smears by Gram stain microscopy is usually inconclusive (Lewisb, 2000). 
The streptobacillary forms of H. ducreyi have been described as “schools of fish”, “railroad 
tracks”, and “fingerprints” (Albritton, 1989). These morphological criteria can be used as a 
presumptive microscopic identification for H. ducreyi but its sensitivity and specificity has not 
been shown to be suitable for routine use (Albritton, 1989).  
 
Electron microscopy biopsies were also suggested for diagnosis of chancroid but like the 
Gram stain, the sensitivity and specificity of the technique is unacceptable for routine use 
(Albritton, 1989).  
 
2.7.1.2 In vitro Culture 
Since H. ducreyi is a fastidious (Morse, 1989) microbe it is important that they maintain their 
viability after the collection of clinical specimens, until it is inoculated onto appropriate media 
at a diagnostic laboratory (Trees and Morse, 1995). This became possible with the 
development of a thioglycolate-hemin-based transport media which was shown to be a viable 
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method for the recovery of H. ducreyi after 4 days from specimens stored at 4oC (Dangor et al, 
1993).    
 
In vitro culture for H. ducreyi was once considered the gold standard for evaluating newer 
techniques of diagnosis (Lewisb, 2000). However, culture techniques for diagnosing chancroid 
have now been abandoned and replaced by DNA amplification techniques. Despite this, such a 
test is not commercially available (Al-Tawfiq and Spinola, 2002). The sensitivity of 
H. ducreyi  culture relative to PCR is reported to be around 75% (Lewisb, 2000; Lewis, 2003). 
 
The fastidious nature of H. ducreyi makes it a difficult microorganism to isolate from genital 
ulcer specimens (Trees and Morse, 1995). Therefore obtaining a pure culture of H. ducreyi 
from genital ulcers has proved to be difficult with isolation rates ranging from 0 to 25% 
(Hammond et al, 1978). A number of factors could be responsible for the different isolation 
rates but it has been pointed out that the type of growth factor supplement used, namely, 
IsoVitaleX [BBL], Vitox [Oxoid], and CVA [GIBCO] is unlikely to be responsible since the 
compositions of these supplements are similar. The only difference is that CVA enrichment 
contains 25.0 g of cysteine HCl per litre, whereas IsoVitaleX and Vitox contain 25.9 g of 
cysteine HCl per liter (Trees and Morse, 1995). The main factor influencing varying isolation 
rates is likely the differences in composition of the growth media and differences in nutritional 
requirements amongst the H. ducreyi strains (Trees and Morse, 1995). 
 
The media of choice until 1978 were 30% rabbit blood agar and whole blood (Sturm and 
Zanen, 1984), and it was in this year that Hammond et al (1978) had introduced the use of a 
selective media which consisted of chocolate agar (CA) with IsoVitaleX for the isolation of 
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H. ducreyi. In this study the addition of 3 µg/ml of vancomycin to CA had resulted in the 
reduction of contamination with an increased amount of H. ducreyi (Hammond et al, 1978).  
However it has been reported that the addition of 3 µg/ml of vancomycin inhibits the growth 
of some clinical strains of H. ducreyi (Lewisa 2000; Lewisb, 2000). In 1981, Sturm described a 
modification of Bieling medium which had originally been developed for the isolation of 
gonococci. This medium containing lysed horse blood was successful in obtaining excellent 
growth with 48 strains of H. ducreyi (Sturm and Zanen, 1984).  
 
The development of numerous selective artificial media for the growth of H. ducreyi has been 
summarized previously and reviewed by Morse in 1989 and again by Trees and Morse in 1995 
(Morse, 1989; Trees and Morse, 1995). The combination of two media was proposed, namely 
Mueller-Hinton agar supplemented with 5% chocolate horse blood (MH-HB) and gonococcal 
agar supplemented with 2% bovine haemoglobin and 5% fetal calf serum (GC-HgS). This 
combination of media resulted in the isolation of H. ducreyi in 90% of chancroidal cases 
(Lewisb, 2000). A suitable cheaper option was also recommended which consisted of a media 
containing a gonococcal agar base supplemented with 5% Fildes’ extract and unchocolated 
horse blood. This medium may serve as a cheaper option to GC-HgS or MH-HB and was 
successful in isolating H. ducreyi in 75% of chancroidal cases (Lewisb, 2000). Another 
affordable media was also described which consisted of 0.2% activated charcoal as a substitute 
for fetal calf serum (Lewisb, 2000). 
 
Sturm and Zanen (1984) and Schmid et al (1995) had both found that most H. ducreyi strains 
grew best at 33oC for the cultivation of fresh H. ducreyi isolates and the primary isolation of 
H. ducreyi from ulcers, respectively (Sturm and Zanen, 1984; Schmid et al, 1995). 
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Furthermore, Sturm and Zanen (1984) had reported excellent growth of 29 H. ducreyi strains 
under campylobacter conditions. This was achieved by incubating plates cultured with 
H. ducreyi in a closed anaerobic jar consisting of two CO2 and H2 generating sachets with the 
absence of a catalyst (Sturm and Zanen, 1984). 
 
2.7.1.3 Polymerase chain reaction (PCR) 
DNA amplification based techniques appear to offer a more sensitive and specific approach 
for the diagnosis of chancroid. It is for this reason that several PCR – based techniques have 
been developed and are used in clinical studies of genital ulcer disease. So far, the 
development and design of the different PCR assays have used specific primers to amplify 
sequences from either the H. ducreyi 16S ribosomal RNA gene, the rrs (16S) – rrl (23S) 
ribosomal intergenic spacer region, an anonymous fragment of cloned H. ducreyi DNA, or the 
groEL gene which encodes the H. ducreyi GroEL heat shock protein (Lewisb, 2000). 
 
A number of different PCR assays designed previously were able to detect H. ducreyi in 
genital ulcer specimens with sensitivities constantly ranging from 80% to 100% as compared 
with culture (Parsons et al, 1995). However to an extent, some PCR assays performed on 
genital ulcer specimens were noted to be less sensitive as compared to samples prepared from 
H. ducreyi culture. The lessened sensitivity obtained from the genital ulcer specimens was 
attributed to Taq polymerase inhibitors present in the DNA preparations of the specimens. 
Sodium phosphate was said to be responsible for this observation which is present in the 
specimen transport medium (Lewisb, 2000).  
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Orle et al (1996) has developed a Multiplex PCR (M-PCR) assay that simultaneously 
amplifies DNA targets from Treponema pallidum, Haemophilus ducreyi and herpes simplex 
virus (HSV) types 1 and 2 (Orle et al, 1996). Orle et al (1996) reported that their M-PCR 
assay was found to be more sensitive than standard diagnostic tests for the simultaneous PCR 
detection of HSV, H. ducreyi, and T. pallidum from genital ulcers with sensitivities of 100, 
98.4 and 91%, respectively (Orle et al, 1996). Their M-PCR has been developed by Roche 
Molecular Systems (National Guideline for the Management of Chancroid, 2001; Alfa, 2005) 
but has been used for research purposes only (National Guideline for the Management of 
Chancroid, 2001). 
 
PCR or nucleic acid amplification is regarded as the gold-standard test for the diagnosis of 
chancroid (Al-Tawfiq and Spinola, 2002), but is not yet available commercially (Al-Tawfiq 
and Spinola, 2002; Lewis and Ison, 2006). 
 
The use of PCR for diagnosis not only improved the sensitivity of laboratory diagnosis of 
chancroid but also made it possible to transport specimens over longer distances (Totten et al, 
2000). However, one needs to take into account the time frame between collecting the 
specimen and laboratory result, mainly when the PCR assay is done off-site (Totten et al, 
2000), as one needs to consider the viability of the specimen when testing is eventually 
performed.  
 
However even though such DNA amplification based techniques prove to be sensitive, it is 
still not feasible for resource poor countries to implement these due to the high costs involved. 
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2.7.1.4 Polyclonal/monoclonal antibodies and antigen detection 
The role of immunofluorescence assays as a diagnostic tool for the direct detection of 
H. ducreyi in smears is limited. The reason for this is the low concentration of bacteria in ulcer 
specimens and the poor specificity of polyclonal anti-sera. The use of more specific 
monoclonal antibodies could circumvent this problem but these are not readily available 
(Trees and Morse, 1995). 
 
 An indirect immunofluorescence assay was developed for the detection of H. ducreyi which 
utilized antiserum raised in rabbits. In order to eliminate cross-reactivity the antiserum had to 
be extensively absorbed with Haemophilus species. However even after absorption the 
interpretation of a positive smear was often difficult because a degree of fluorescence was still 
observed with various Haemophilus sp, Staphylococcus aureus and Bacteroides 
melaninogenicus. Furthermore it was not possible to assess whether cross-reacting antibodies 
were present prior to immunization as pre-immunization sera was not obtained (Trees and 
Morse, 1995). 
 
Finn et al (1990) had described the use of an indirect immunofluorescence assay for the 
detection of H. ducreyi which utilized rabbit antiserum and mouse monoclonal antibodies 
raised against a strain of Haemophilus ducreyi. The antiserum and the three monoclonal 
antibodies produced high immunofluorescence titres with all H. ducreyi strains tested. In the 
case of the rabbit antiserum, cross reaction was only observed with Bordetella pertussis. The 
monoclonal antibodies were shown to react with a single polypeptide band of molecular 
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weight 29 kDa (kilodalton) which was found to be located in the outer membrane fraction of 
H. ducreyi (Finn et al, 1990). 
 
Another development was in the form of an immunofluorescence reagent (IF) where a 
monoclonal antibody (MAb) was raised against a 29 kDa outer membrane protein (OMP) in 
H. ducreyi. The sensitivity and specificity of the MAb as a IF reagent was evaluated by testing 
it on simulated H. ducreyi vaginal smears, smears from skin lesions of mice infected with 
H. ducreyi and genital ulcer smears from patients clinically diagnosed with chancroid. The IF 
test was able to identify more than 90% of culture positive cases of chancroid, as well as some 
of the culture negative cases. This data suggest that the 29 kDa OMP could potentially be a 
useful means of detecting H. ducreyi in clinical specimens (Karim et al, 1989).   
 
Trees and Morse (1995) have summarized a number of studies involving MAbs that react with 
antigens of H. ducreyi (Trees and Morse, 1995). Some of these MAbs which have been 
described previously by other authors appear as promising reagents for the direct detection of 
H. ducreyi in genital ulcer smears (Trees and Morse, 1995). 
 
Patterson et al (2002) had developed a rapid diagnostic immuno-chromatography (IC) test 
based on monoclonal antibodies to the hemoglobin receptor of H. ducreyi, HgbA. The 
sensitivity and specificity of the IC test was evaluated by using strains of H. ducreyi of 
different origin, other Haemophilus strains, and bacteria that cause super infection of genital 
ulcers. They reported specificity of 100% since all H. ducreyi strains tested were positive and 
all other bacteria tested were negative. With their test the least amount of colony forming units 
(CFU) of H. ducreyi detected was 2 x 106 CFUs, and the lowest amount of purified HgbA 
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protein detected was 8.5 ng. They concluded that on a clinical setting this level of sensitivity 
may not likely be enough to detect H. ducreyi in all specimens, but additional work needs to 
be done in order to improve the sensitivity of the test thus making it a valuable bedside tool for 
the rapid diagnosis of H. ducreyi infection (Patterson et al, 2002). 
 
2.7.1.5 Nucleic acid probe technology 
DNA-DNA hybridization techniques have been developed for the detection of H. ducreyi 
DNA by the use of labelled H. ducreyi derived probes (Lewisb, 2000). Parsons et al  (1989) 
reported the development of three 32P labelled DNA probes for H. ducreyi. The DNA probes 
were evaluated on their ability to hybridize with H. ducreyi DNA and were able to detect 104 
CFUs of H. ducreyi in mixed and pure cultures. They reported that the DNA probes reacted 
strongly with 16 strains of H. ducreyi and no reactivity was observed with Treponema 
pallidum, Neisseria gonorrhoea, or HSV DNA (Parsons et al, 1989). However, Trees and 
Morse (1995) went on to report that DNA probes are not sensitive enough to detect H. ducreyi 
in clinical specimens (Trees and Morse, 1995). The sensitivity for the above test could be 
greatly increased in clinical specimens due to the possibility of initial amplification of 
H. ducreyi DNA in the specimen by directly growing the bacteria or by DNA amplifying 
procedures (Lewisb, 2000). 
 
Specific rRNA-derived oligonucleotide probes have also been developed by Rossau et al 
(1991). These chemically synthesised probes were complementary to different regions in the 
16S and 23S rRNA molecules of H. ducreyi. The testing of culture grown isolates with these 
probes by means of DNA-RNA hybridization techniques were reported to be very specific for 
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detecting H. ducreyi. However no data was given on the sensitivity of the technique (Rossau et 
al, 1991). 
 
 2.7.1.6 Serological tests 
Techniques such as enzyme immunoassays (EIAs), dot-immunobinding, agglutination, 
precipitation and complement fixation have been used to identify serological responses in 
humans and experimental animals acquiring chancroid (Lewisb, 2000). EIAs which have been 
developed either uses ultra sonicated whole-cell H. ducreyi antigens, purified H. ducreyi lipo-
oligosaccharide or outer membrane proteins as antigens, all of which have been assessed in the 
serological diagnosis of chancroid (Lewisa, 2000; Lewisb, 2000).  
 
However, difficulties have been faced in interpreting results when using EIAs due to the 
presences of cross-reacting antibodies in serum specimens from control patients. This problem 
was overcome by adsorbing the serum to remove the cross-reacting antibodies (Elkins et al, 
2000). An improvement in the specificity of EIA was observed when serum was adsorbed 
with other Haemophilus sp namely, H. parahaemolyticus, H. influenzae, H. parainfluenzae to 
remove cross-reacting antibodies prior to testing (Lewisa, 2000). Using PCR as the gold 
standard for diagnosing H. ducreyi infection with genital ulcer material, Chen et al (1997) was 
able to demonstrate that the adsorption EIA had a sensitivity of 53 % and a specificity of 71% 
whereas the LOS EIA was less sensitive (48%) but more specific (89%). When follow up sera 
results were included in the analysis, there was an increase in both the sensitivity (78%) and 
specificity (84%) of the adsorption EIA. This increased sensitivity and specificity of the 
adsorption EIA merely suggested that the proportion of patients testing positive for H. ducreyi 
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infection had increased as the infection advanced to ulcerative stage. Therefore the adsorption 
EIA is hindered as a diagnostic tool because of the lack of sensitivity observed during the first 
few weeks of infection and seemed to improve as infection progressed (Chen et al, 1997).  
 
2.7.1.7 Mass spectrometric methods 
Matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI/TOF – 
MS) has been found to be successful in profiling proteins from both intact and disrupted 




As far back as the 1970s, documentation shows that H. ducreyi acquires both plasmid and 
chromosomally mediated mechanisms of antimicrobial resistances which posed as a problem 
world-wide. Even though not much is known about chromosomally mediated antimicrobial 
resistance, reduced susceptibility has been documented for trimethoprim, penicillin, 
ciprofloxacin and ofloxacin in non plasmid – containing H. ducreyi strains (Lewisa, 2000). 
Most accessible information concerns plasmid-mediated resistance.  Plasmids present in 
H. ducreyi strains encode for resistance to more than one class of antimicrobial agent. 
Furthermore, more than one resistance – encoding plasmid may be present in the same 
H. ducreyi strain (Lewisa, 2000). H. ducreyi strains have shown to possess plasmid-mediated 
resistance to tetracycline, chloramphenicol, sulphonamides, aminoglycosides, and β-lactam 
antimicrobial agents (Lewisa, 2000).  
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Treatment recommended by both the World Health Organisation (WHO, Guidelines for the 
Management of STIs, 2003) and the Centres for Disease Control and Prevention (CDC, 
Sexually Transmitted Disease Treatment Guidelines, 2006) are outlined in table 2.1. 
According to the CDC, ceftriaxone and azithromycin is an advantageous option in that it 
offers single dose therapy (CDC, Sexually Transmitted Disease Treatment Guidelines, 2006). 
This option avoids problems with compliance (Trees and Morse, 1995). Azithromycin (1g 
orally, once), ceftriaxone (250mg intramuscularly, once), or erythromycin (500mg orally, four 
times a day for 7 days) was reported to be successful treatment strategies for chancroid in the 
United States (Schmid, 1999).  
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World Health Organisation 
(WHO) 
 






1 g orally, single dose 
 




250 mg by intra-muscularly (IM) in 
a single dose 
 





500 mg orally, twice daily for 3 days 
 






500 mg orally, 4 times daily for 7 
days 
 
500 mg orally, 3 times daily for 7 
days 
* Ciprofloxacin is contraindicated for pregnant and lactating women as stipulated by the   
CDC, Sexually Transmitted Disease Treatment Guidelines, 2006. 
 
Uncircumcised or HIV positive patients may not respond well to treatment as compared to 
those patients who are circumcised or HIV-negative (CDC, Sexually Transmitted Disease 
Treatment Guidelines, 2006). Two studies reported on differences between circumcised and 
uncircumcised men. In one study the cure rate in the uncircumcised men was 82% compared 
with 93% in circumcised men; the second study showed cure rates of 59% and 94%, 
respectively (Schmid, 1999). Since a positive HIV status and a lack of circumcision has been 
associated with a less favourable response to therapy, it is recommended that for management 
purposes, all patients should be tested for HIV and if found to be HIV positive then treatment 
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in these patients should be followed more closely (Schmid, 1999; CDC, Sexually Transmitted 
Disease Treatment Guidelines, 2006). Longer treatment regime maybe required (Steen, 2001). 
The same should apply for uncircumcised men, where a close follow-up during treatment is 
also recommended if diagnosed with chancroid (Schmid, 1999). 
 
According to the 2006 treatment guidelines of the CDC, at the time when chancroid is 
diagnosed, patients should be tested for HIV infection and then retested three months later for 
syphilis and HIV infection if these test results were initially negative. A follow-up 
examination is recommended where patients will be re-examined 3-7 days after initiation of 
therapy. If treatment is found to be successful within this time period after therapy, then ulcers 
would usually improve symptomatically. However if clinical improvement is unsatisfactory, 
the attending clinician needs to consider the following:  1) is the diagnosis correct, 2) is the 
patient co-infected with another STD, 3) is the patient infected with HIV, 4) is treatment used 
correctly, or 5) is the H. ducreyi strain which is responsible for infection resistant to the 
antimicrobial prescribed (CDC, Sexually Transmitted Disease Treatment Guidelines, 2006). 
 
In regards to the treatment of buboes as a result of H. ducreyi infection, it is said that the 
drainage or the aspiration of fluctuant buboes results in symptomatic relief and may also 
prevent subsequent rupture (Lewisa, 2000; Lewis, 2003). A study done in New Orleans has 
addressed the issue concerning the re-accumulation of pus in the bubo site which may have 
required re-aspiration. They recommend the incision and drainage of buboes with subsequent 
packing as an effective method for treatment, thus avoiding re-aspiration (Ernst et al, 1995). 
This might not be an appropriate approach in developing countries where follow-up is usually 
inadequate (Ernst et al, 1995). 
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2.9 Chancroid and HIV transmission 
Apart from the fact that chancroid is a painful genital ulcer disease (GUD), it is also an 
independent risk factor for the heterosexual transmission of the human immunodeficiency 
virus (HIV), making it an important public health problem (Elkins et al, 2000).  H. ducreyi 
infections may influence HIV transmission by one of the following mechanisms, (Spinola et 
al, 2002):  
1. The provision of an available portal of viral entry;   
2. Viral shedding from the ulcer;  
3. Increased viral load in blood and semen, and;  
4. Recruitment of CD4 carrying cells into the skin. 
 
 In addition, the primary HIV-1 target cells, CD4 T cells have been isolated from within 
chancroid ulcers (Elkins et al, 2000). It is likely that the break in epithelial lining and the 
accumulation of CD4 carrying cells result in increased HIV transmission (Lewisa, 2000). 
Furthermore, mathematical models propose that the transmission of HIV and it’s relatedness 
to GUD has played an important part in amplifying the HIV epidemic in Sub-Saharan Africa 
(Spinola et al, 2002). Data from Kenya and Thailand suggest an increased risk of HIV 
transmission as much as 50-300 times per unprotected sex act as a result of genital ulcers. 
Therefore in countries where GUD is common, a large number of new HIV infections can be 
expected. Strong associations have also been reported between GUD and HIV seropositivity 
with odds and risk ratios being higher as compared to non ulcerative STDs (Steen, 2001).  
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Even though the incidence and prevalence of H. ducreyi infection differ by country and 
region, a close geographical association has been reported to exist between HIV infection and 
chancroid, which has been observed in African and Asian countries (Steen, 2001).  
  
2.10 Heat shock proteins 
A group of proteins called Heat Shock Proteins (HSPs) are synthesized by all organisms in 
response to heat. In addition, HSPs are also induced by a variety of other stresses which may 
include heat, anoxia and exposure to ethanol and certain heavy metal ions. Such group of 
proteins are highly conserved, existing in both prokaryotic and eukaryotic organisms, and even 
though certain characteristics of the response may differ among organisms, many are said to 
be nearly universal or universal (Lindquist and Craig, 1988).  
 
In addition, HSPs also exist in all organisms at normal temperature and are said to play 
essential roles in the normal functioning of the cell. It is assumed that the heat-shock response 
and its induction of HSPs synthesis may protect cells from the toxic effects of heat and other 
stresses that may have induced its production. The induction of the HSP response differs in 
each organism and occurs at very different temperatures; the organism in question is therefore 
expected to deal with such temperatures in their natural environment (Lindquist and Craig, 
1988). Apart from their role in thermotolerance, HSPs have also been implicated in 
immunodominance and autoimmunity (Parsons et al, 1992). Antibodies and activated T cells 
have been shown to react with major HSPs of organisms like Mycobacterium leprae, 
M. tuberculosis, Coxiella burnetti, Plasmodium falciparum, Schistosoma mansoni, Brugia 
malayii, Trypanosoma cruzi and Leishmania (Lindquist and Craig, 1988).   
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Although not generally associated with the surface of the cell, many HSPs occur as 
immunodominant antigens. This strong immunogenicity can perhaps be explained by the 
abundance of these proteins allowing these to be processed and presented to lymphocytes 
following phagocytosis by antigen presenting cells (Lindquist and Craig, 1988). In addition, 
HSPs might be further induced due to the hostile environment in the macrophages in particular 
if the organism is a macrophage pathogen (Lindquist and Craig, 1988). 
 
Two genes, groEL and groES described previously, consist of an operon under heat shock 
control positioned at 93.5 minutes on the Escherichia coli chromosome. These genes encode 
for the abundantly produced proteins, groEL a 65 kd Mr protein and groES a 15 kd Mr 
protein, which is said to be vital for cell growth at all temperatures (Lindquist and Craig, 
1988). In addition, GroES and GroEL HSPs are essential for E. coli to maintain its cell 
viability at all temperatures (Parsons et al, 1992). GroE HSPs increase in abundance when 
cells are stressed and protect essential proteins from denaturation (Parsons et al, 1992). 
 
Parsons et al (1992) had identified two adjacent open reading frames (ORFs) in which 
H. ducreyi encodes for a GroES HSP and GroEL HSP, of 10.3 kDa and 57.8 kDa, 
respectively. The H. ducreyi HSPs genes were found to show homology with the groE genes, 
and thus with the GroES and GroEL heat shock proteins from a number of other bacterial 
pathogens, as well as the conserved eukaryotic 60 kDa HSP (Parsons et al, 1992). Parsons et 
al (1992) had noticed high levels of groE mRNA from exponentially growing H. ducreyi in 
hemin broth when grown optimally at 33oC. Furthermore a heat-inducible, immunoreactive 
protein of about 60 kDa (GroEL) was found to be the pre-dominant protein produced by the 
exponentially growing H. ducreyi (Parsons et al, 1992).   
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Brown et al (1993) had reported on an increased synthesis of a 58.5 kDa HSP of H. ducreyi 
when grown between 30oC and 33oC, which had also appeared to be the dominant protein in 
the cell lysate. Due to its molecular weight and its heat shock inducibility, Brown et al (1993) 
suggested that it was the GroEL homologue and thus a member of the HSP60 family (Brown 
et al, 1993). 
 
Induced heat shock with an increase from 33oC (optimal growth temperature) to 37oC had 
improved the thermostability of H. ducreyi, making stressed cells capable of withstanding the 
effects of rapid chilling on ice. Such an effect is attributed to the expression of other heat 
shock proteins which are necessary to maintain thermostability when stressed H. ducreyi cells 
were subjected to heat shock. In contrast, the expression of the relatively high levels of the 
groE operon seen in exponentially growing H. ducreyi prior to heat shock was insufficient to 
protect the cells from death by rapid chilling (Parsons et al, 1992). 
 
By investigating the response to heat shock in H. ducreyi, Brown et al (1993) had identified 
four HSPs of molecular weights, <14, 58.5, 74 and 78 kDa. They achieved this by labelling 
newly synthesized proteins of H. ducreyi with a pulse of 35S-methionine and measured its 
production at temperatures ranging between 30oC – 40oC. By means of Western blot, the 
protein profiles were also probed with serum from an immunized rabbit, serum from a rabbit 
infected intradermally with H. ducreyi, mouse monoclonal antibodies (MAb) and a pool of 
human sera from patients with chancroid. The sera from the rabbits, the pooled human serum 
and the MAb, BB11 had reacted with epitopes on the 58.5 kDa HSP. The serum of the 
immunized rabbit and another MAb, CC11 had reacted with epitopes on the 78 kDa HSP. 
Their findings had showed that the 58.5 kDa HSP was immunogenic in the human and rabbit 
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model, and therefore plays a role in the immune response and the pathogenicity of H. ducreyi 
(Brown et al, 1993).  
 
Frisk et al (1998) had demonstrated that the GroEL homolog of H. ducreyi, the 58.5 kDa HSP 
is not only produced in response to heat but also under in vitro growth conditions. The GroEL 
HSP is normally considered to be an intracellular located protein; however it was shown that 
in H. ducreyi, the 58.5 kDa HSP is also present on the cell surface (Frisk et al, 1998). 
Therefore by demonstrating the attachment of the 58.5 kDa HSP to eukaryotic cells, it implies 
the possibility of the HSP being involved in the attachment of bacteria to host cells (Frisk et 
al, 1998). In addition, Pantzar et al (2006) had demonstrated the attachment of the 58.5 kDa 
GroEL HSP of H. ducreyi to several glycosphingolipids and this was reported to signify a 
potential bacterial adhesion mechanism (Pantzar et al, 2006). 
 
2.11 Control strategies for chancroid 
The diagnosis of chancroid is difficult and unreliable when based on culture (Sottnek et al, 
1980; Steen, 2001) and clinical presentation (Lewisb, 2000, Steen, 2001). Furthermore these 
developing and resource poor countries may lack the laboratories and experienced medical 
staff for the etiological diagnosis of STIs. It is for these reasons that emphasis has been placed 
on the development of ‘Syndromic Management’ of STIs by the World Health Organisation. 
This strategy contributes to the effective control and possible eradication of STIs. “The 
syndromic management approach is based on the identification of consistent groups of 
symptoms and easily recognized signs (syndromes), and the provision of treatment that will 
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deal with the majority of, or the most serious, organisms responsible for producing a 
syndrome” (WHO, Guidelines for the Management of STIs, 2003). 
 
South Africa’s Department of Health developed its own guidelines (figure 2.2) for syndromic 
management of STIs in 1995 and has adjusted these guidelines regularly based on changing 
prevalence in the aetiology of the syndromes and susceptibility patterns of the organisms 
(Data provided by Professor A.W. Sturm, Department of Medical Microbiology, Nelson R. 






Figure 2.2: South African guidelines for Syndromic Management of genital ulcers 
36 
Hawkes et al (1995), had report on a small group of women (2%) in Gambia, namely 
commercial sex workers who had shown positive results when tested for chancroid by means 
of PCR, however these women possessed no signs or symptoms of the disease. These findings 
have important implications on syndromic management and control programmes for STDs as 
these infected asymptomatic women are likely to spread infection to their partners (Hawkes et 
al, 1995). It is for this reason that “persons who have had sexual contact with a patient who 
has chancroid within the 10 days before onset of the patient’s symptoms should be examined 
and treated even in the absence of symptoms” (UK National Guideline for the Management of 
Chancroid, 2007).  However, testing or treating asymptomatic individuals for chancroid is not 
generally recommended (Lewis and Ison, 2006). 
 
Bosu (1999) had outlined the advantages and disadvantages (table 2.2) concerning the 
approach to syndromic management. He concluded that even though “the approach is both 
rational and scientific” (Bosu, 1999), and that the advantages may seem to overshadow its 
disadvantages, focus should lie on each specific setting adopting the approach as one needs to 
take into account the differences in STD epidemiology, operational issues, acceptability and 








Table 2.2: Advantages and disadvantages of Syndromic case management (Bosu, 1999) 
Criteria Advantages Disadvantages 
Algorithm Simple 
Problem-orientated; based 
on presenting symptoms 
Low sensitivity and 
specificity for cervical 
gonococcal and chlamydial 
infections in women. 
Risk scores are not highly 
sensitive or specific. 
Initiation of therapy Rapid. Patients are treated 
at first visit without need 
for laboratory confirmation. 
Not easily accepted by 
doctors. 
Treatment outcome High rates of cure Requires surveillance of 
antibiotics susceptibility 
profiles. Some algorithms 
do not provide for 2nd or 3rd 
line treatment. 
Cost Saves money on laboratory 
tests. Cost-effective. 
Leads to over treatment 
which may be costly 
Coverage Can achieve high coverage 
of population 
Does not detect 
asymptomatic cases 
Implementation Can be easily integrated 
into the PHC system. 
Can rely on non medical 
staff to manage cases. 





supervision and ordering of 
drugs. 
Facilitates data collection 
for surveillance and 
planning. 
May have to set up a 
parallel information system 




The CDC contributes to the management of STDs by calling upon STD/HIV prevention 
counselling which relies on the “effective delivery of prevention messages which requires that 
providers integrate communication of general risk reduction messages that are relevant to the 
client (i.e., client-centered counseling)” (CDC, Sexually Transmitted Disease Treatment 
Guidelines, 2006). These counselling sessions aim to educate clients about reducing the risks 
of STD/HIV infection and include topics such as abstinence, condom use, having fewer sex 
partners, changing sexual behaviours and vaccination (CDC, Sexually Transmitted Disease 
Treatment Guidelines, 2006). 
 
According to Steen (2001), chancroid is a suitable STI for eradication because it meets three 
important criteria:  
1. The infection can be identified, both syndromically and aetiologically. Treatment is 
rapid and accuracy of disease surveillance is improved;  
2. Chancroid is a curable infection due the availability of a number of effective single 
dose antimicrobial treatments, one which is known to provide broad post treatment 
prophylaxis, and finally; 
3. H. ducreyi does not have a non-human reservoir and can only be sustainable within 
sub-groups of the population as a result of sexual networks and therefore somewhat 
restricted. 
 
Therefore an effort to eliminate and eradicate chancroid from endemic areas remains a 
possible one (Steen, 2001).  
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Important control measures such as condom distribution, education on disease transmission, 
preventative behaviour or measures, the availability of special clinical services which allows 
for regular examinations and treatment for high risk individuals has been found to be effective 


















Chapter Three: Material and Methods 
 
3. Ethical Approval 
Ethics approval was obtained from the Animal Ethics Sub-Committee of the University Ethics 
Committee, University of KwaZulu-Natal. Reference: 021/07/Animal. 
 
3.1 Bacterial Isolates 
Haemophilus ducreyi strains A54 and A68 were obtained from the Department of Medical 
Microbiology at the Nelson R. Mandela School of Medicine, University of KwaZulu Natal. 
These strains were clinical isolates collected during projects run by the Department of Medical 
Microbiology. 
 
3.2 Growth and harvesting of H. ducreyi  
Bacteria were revived from stock samples stored in cryovials at - 80oC. Bacteria was grown on 
Modified Bieling (MB) agar plates (appendix 1) as well as in MB broth (appendix 1), and 
incubated at 33oC for 48 hours under microaerophilic conditions. Gram stained smears 
(appendix 2) were done on culture obtained from MB agar plates and MB broth to confirm 
culture purity.  
 
Initially, bacteria was cultured on solid medium (10 MB agar plates) which was then scraped 
off after 48 hours and grown in 30 ml of MB broth for a further 48 hours to increase the 
biomass. Inoculated broth was then centrifuged for 20 minutes at 3000 x g. The supernatant 
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was discarded and the bacterial pellet was washed two to three times with 2 ml phosphate 
buffered saline (PBS) (appendix 6) until pellet was clearly visible. 
 
3.3 Lysis of bacterial cells 
The bacteria were sonicated with a Branson Sonifier 250, for 5 minutes at a duty cycle of 50 
and a control output of 6. During the sonication process, the tube containing the bacteria was 
placed in ice to prevent heating of bacterial contents. 
 
The sonicated sample was centrifuged for 15 minutes at approximately 4000 x g. The 
supernatant was filter sterilized through 0.2 micron filters (Millipore, USA) and the pellet was 
discarded. The resulting bacteria free filtrate was screened on SDS PAGE gels (appendix 3 
and 4) and the remainder was aliquoted into eppendorf tubes and stored at - 20oC until further 
use. 
 
3.4 Separation of the proteins and estimation of molecular weight 
Separation of the proteins and estimation of its molecular weight was performed with sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) (appendix 3 and 4), 
according to Bio-Rad’s instruction manual. Large gel slabs were prepared with one large well 
and one small well, to which 400 µl of prepared bacteria free filtrate and protein Molecular 
Weight (MW) standard (Fermentas, USA) were loaded, respectively. Prior to loading the large 
well, 300 µl of bacteria free filtrate was mixed with 100 µl of sample reducing buffer 
(appendix 3). The final 400 µl of prepared bacteria free filtrate sample was transferred into the 
large well in the sodium dodecyl sulphate polyacrylamide gel. The small well received 10 µl 
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of the protein standard. The loaded gel was allowed to run at a voltage of 100 volts and a 
current of 50 amps for approximately 6 hours.   
 
3.5 Localisation of 58.5 kDa heat shock protein 
A method described previously was used (Nurhadi et al, 2003). After completion of the gel 
electrophoresis (3.4), two longitudinal strips, including the portion of gel used for the protein 
standard were cut from the sides of the gel and stained with Coomassie Blue solution 
(appendix 3) until protein bands were visible. The remainder of the gel was left to rest on a 
glass plate in the refrigerator. After the two strips of the gel were stained, the excess of 
Coomassie Blue dye was removed by destaining the gel strips with destaining solution 
(appendix 3). The two destained strips were then lined up along the edges of the unstained gel 
(from refrigerator) and used as a guide to locate the band of interest in the 58.5 kDa region in 
the unstained gel. This presumed 58.5 kDa band was cut out with a sterile blade and the pieces 
of gel were stored in sterile eppendorf tubes in a refrigerator until further use. 
 
3.6 Protein elution from gel matrix 
The elution process was adopted from Nurhadi et al (2003) with some modification (Nurhadi 
et al, 2003). The pieces of gel containing the band of interest were minced with a sterile blade. 
The minced gel pieces were washed three times with 1 ml of sterile distilled water. A 
maximum of 500 µl of protein elution buffer (appendix 5) was then added. The suspension 
was vortexed and allowed to stand overnight at room temperature. The next day, the mixture 
was centrifuged at 21 000 x g for 10 minutes, after which the supernatant was collected into a 
clean eppendorf tube. A further 250 µl (maximum) of the protein elution buffer was added to 
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the gel pieces, vortexed and centrifuged. The resulting supernatant was combined with the first 
500 µl of eluted protein. An aliquot of the supernatant was then tested for the presences of the 
58.5 kDa protein by means of SDS-PAGE. 
 
3.7 Purification of proteins 
Proteins were purified by means of a protein purification kit, the ProteoSpin detergent clean-
up kit (Norgen Biotek Corp., Canada) and protein was quantified by the Qubit™ Quantitation 
Platform (Invitrogen Corp., USA), according to the manufacturer’s instructions. Purified 
proteins were aliquoted into 100 µl volumes in sterile tubes and stored at - 20oC until further 
use. 
 
3.8 Production of polyclonal antibody 
Antibodies to the H. ducreyi 58.5 kDa GroEL heat shock protein (antigen) were raised in 
rabbits at the Biomedical Resource Unit, Westville campus, University of KwaZulu Natal. 
Three New Zealand white rabbits were used for this procedure.  
 
3.8.1 Bleeding of rabbit 
The rabbit was placed in a restrainer. The ears were shaved using a soapy liquid and surgical 
blade. The ear was rinsed, dried and disinfected with ethanol (or other antiseptic). A 20G 
needle was inserted into the ear vein and blood was collected in a 5 ml blood tube. The needle 
was removed and pressure was applied using cotton wool to prevent further bleeding. The 
collected blood was allowed to clot and the serum collected. The baseline antibody level 
against the 58.5 kDa H. ducreyi protein was measured using an ELISA.  
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3.8.2 Rabbit immunisation  
On day 0 a 1 ml purified antigen (50 µg/ml protein) mixed with equal volume of Freund’s 
Complete Adjuvant (FCA) was prepared using 2 interconnecting glass syringes. Of this, 0.5 
ml was injected intra-muscularly into each hind leg. The rabbits received Booster injections of 
0.25 ml (50 µg/ml) antigen solution without FCA in each hind leg on days 10 and 20. On day 
28, 5 ml of blood was collected as described before (3.8.1) to test for immune response.  
 
When a good immune response was achieved, the rabbit was sedated using a combination of 
xylazine (0.6 ml) and ketamine (0.6 ml) administrated intra-muscularly, and was bled by 
cardio-puncture. The blood was collected in 5 ml blood tubes and kept at room temperature 
until a clot was formed. Serum was collected after centrifugation, aliquoted and stored at -
20oC. The rabbit was eventually terminated by intravenous sodium pentobarbitone injection. 
The carcass was incinerated at the Biomedical Resource Unit. 
 
3.9 Purification of IgG 
Polyclonal antibodies against the 58.5 kDa heat shock protein were purified by means of 
ProSep A chromatography media (Millipore, USA).  
 
3.9.1 Column preparation 
A 10 ml pre-packed ProSep-A column was used to purify the antibody. The ProSep-A media 
within the column was poured out into a 250 ml glass beaker containing 50 ml phosphate 
buffered saline (PBS), pH 7.4 (appendix 6). The empty column was then half filled with PBS, 
pH 7.4. The ProSep-A/PBS mixture was then poured back into the 10 ml column with the aid 
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of a glass rod. As this was done the column was continuously vibrated by hand to ensure the 
proper settling of ProSep-A media within the column. Used columns were regenerated with 
phosphoric acid, pH 1.5 and flushed with PBS, pH 7.4, for the next use. 
 
3.9.2 Purification of the IgG fraction 
Serum was prepared as described previously (Harkins, 2001) with slight modifications. Lipids 
and other cellular debris were removed from the serum by means of centrifugation at 4oC for 
20 000 x g for 30 minutes. The supernatant was then dialysed overnight against PBS, pH 7.4 
(appendix 6). The dialysate was filtered through a 0.45 µm filter (Millipore, USA) before 
loading onto the prepared ProSep-A column (3.9.1). 
 
The column was flushed with PBS, pH 7.4, and the fluid was collected in 1 ml aliquots. 
Absorbance values of these aliquots were obtained by means of spectrophotometry. When an 
absorbance of 0.05 was reached, the PBS was replaced by IgG elution buffer, pH 3 (appendix 
5). When an absorbance value of just greater than 3 was reached, the IgG fraction was 
collected in 1 ml aliquots and dialysed against PBS, pH 7.4, overnight.  
 
3.9.3 Process of dialysis for purified IgG  
A piece of dialysis tubing (Sigma-Aldrich, USA) compatible with the volume of fluid to be 
dialysed was closed at one end with a piece of string. The tube was filled with the IgG fraction 
obtained from column chromatography (3.9.2) and closed. The tube was then suspended into a 
clean glass beaker containing PBS, pH 7.4 (appendix 6). Dialysis was allowed to occur at 4oC, 
overnight. The PBS was replaced 3 times. The following day, the IgG was removed from the 
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dialysis tube and its purity was checked on a SDS PAGE gel. The purified IgG fraction was 
aliquoted into 100 µl volumes. These were stored at - 20oC until further use. 
 
3.10 Enymze linked-immunosorbent assay – ELISA 
Enzyme linked immunosorbent assays (ELISAs) combine the specificity of antibodies with 
the sensitivity of simple enzyme assays, by using antibodies or antigens coupled to enzyme 
where activity can be measured quantitatively. ELISAs are therefore used to measure antigen 
or antibody concentrations. 
 
3.10.1 Determination of optimal coating concentration of antigen   
Sterile 96 well microtitre plates were used. To determine the optimal concentration of the 58.5 
kDa HSP for use as coating antigen, different concentrations were tested. Eight serial 2-fold 
dilutions of the purified antigen were made using coating buffer (appendix 6). The dilutions 
for each concentration was done in 2 ml eppendorf tubes and then transferred into the 
appropriate wells of the microtitre plate. The resulting concentrations were 9 µg/ml, 4.5 µg/ml, 
2.25 µg/ml, 1.12 µg/ml, 0.56 µg/ml, 0.28 µg/ml, 0.14 µg/ml, and 0.07 µg/ml. 
 
One hundred microlitres of antigen with the above respective concentrations were added to the 
wells. The microtitre plate was then covered and placed in a sealed humidified container 
overnight at room temperature. The following day, the plate was washed three times with 200 
µl of wash buffer (appendix 6) per well. The fluid was removed by flicking the plate over a 
sink. The remaining drops were removed by patting the plate on a paper towel. The remaining 
protein binding sites in the coated wells were then blocked by adding 100 µl of blocking 
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buffer (appendix 6). The plate was then covered with a lid and incubated in a sealed 
humidified container for 1 hour at room temperature. The excess blocking buffer was washed 
off with wash buffer and the plate was blotted dry. Fifty microlitre of serum from an 
immunized rabbit was added to each well and the plate was incubated for 1 hour at room 
temperature. The excess serum was removed by washing three times with wash buffer and the 
plate was then blotted dry. Thereafter 100 µl of detection antibody, goat-anti-rabbit-IgG-
horseradish peroxidase (Sigma-Aldrich, USA)  (1:10 000 with 3% skimmed milk powder in 
phosphate buffered saline and 0.01% tween 20 (PBST)) (appendix 6) was added to each well. 
This was followed by incubation in a sealed humidified container for 1 hour at room 
temperature. The excess detection antibody was washed off with wash buffer and the plate 
was blotted dry. To each well, 200 µl of chromogenic substrate (o-phenylenediamine 
dihydrochloride) (Sigma-Aldrich, USA) was added and colour was allowed to develop at 
room temperature. The reaction was stopped by adding 50 µl of 3 M HCl to each well. Colour 
intensity was measured by an ELISA plate reader at 492 nm.  This procedure was carried out 
for each rabbit in triplicate. 
 
3.10.2 Construction of a standard curve 
To determine the optimal antigen concentration, the average of the 3 ELISA absorbance 
readings (3.10.1) per dilution was used to construct a standard curve for each rabbit. The 
average absorbance reading was plotted on the standard curve and the optimal concentration 




3.11 Evaluation of immune response by means of ELISA 
 
To coat the wells of a 96 well microtitre plate, an antigen solution containing 5 µg/ml of 
antigen was made up with coating buffer (appendix 6). One hundred microlitres of the antigen 
solution was added to each well and the plate was covered with a lid. This was followed by 
overnight incubation in a sealed humidified container at room temperature. The next day, the 
remaining antigen solution was discarded and the wells were washed 3 times with 200 µl of 
wash buffer (appendix 6). The plate was then blotted dry. The remaining protein-binding sites 
were blocked by adding 100 µl of blocking buffer (appendix 6) per well. The lid was replaced 
on the plate which was then left to incubate in a sealed humidified container for 1 hour at 
room temperature. Unbound protein was removed by washing the plate three times with wash 
buffer. Rabbit serum was serially diluted two-fold from a 1:5 starting dilution which was made 
up in 2 ml eppendorf tubes. Fifty microlitres of each serum dilution was transferred from the 
eppendorf tubes to the respective wells. The plate was then covered with a lid and incubated in 
a sealed humidified container for 1 hour at room temperature. The excess serum was removed 
by washing (3x) and blotting dry. Thereafter 100 µl of detection antibody, goat-anti-rabbit-
IgG-horseradish peroxidase (Sigma-Aldrich, USA) (1:10 000 with 3% skimmed milk powder 
in phosphate buffered saline and 0.01% tween 20 (PBST)) (appendix 6) was added to each 
well. The plate was then covered with a lid and incubated in a sealed humidified container for 
1 hour at room temperature. The excess detection antibody was washed off (3x) with wash 
buffer and plates were blotted dry. To each well, 200 µl of chromogenic substrate (o-
phenylenediamine dihydrochloride) (Sigma-Aldrich, USA) was added and colour was allowed 
to develop at room temperature. The reaction was stopped by adding 50 µl of 3 M HCl to each 
well. Colour intensity was measured by an ELISA plate reader at 492 nm.  
49 
This ELISA procedure was carried out with serum of each of the three rabbits in triplicate. 
Pre-immunisation serum from each rabbit was used as a negative control.  
For each rabbit, positive/negative (P/N) ratios were calculated for each dilution series by 
taking the average of the three absorbance readings obtained with post-immunisation serum 
and dividing this by the average of the three absorbance readings obtained with pre-
immunisation serum. The P/N ratios were used to choose the rabbit with the optimal immune 
response. IgG from the serum of the rabbit with the optimal response was purified and 
conjugated to horseradish peroxidase following a protocol (appendix 7) provided by Dr. M. 
Bubb, Director of National Institute of Bioproducts, Pinetown, South Africa.  
 
3.12 Determination of optimal concentration of antibodies 
To determine the optimal concentration of capture antibody, a checkerboard titration was 
performed in a 96 well microtitre plate. Five rows of wells were coated with 100 µl capture 
antibody (purified) solution in coating buffer (appendix 6) with the following concentrations: 
100 µg/ml, 80 µg/ml, 60 µg/ml, 40 µg/ml, 20 µg/ml, 10 µg/ml, 5 µg/ml and 1 µg/ml. The plate 
was covered and incubated overnight in a sealed humidified container at room temperature. 
The following day, coating buffer was removed by washing three times with 200 µl of wash 
buffer (appendix 6). The remaining protein-binding sites in the coated wells were then blocked 
by adding 100 µl of blocking buffer (appendix 6). The plate was again incubated in a sealed 
humidified container for 1 hour at room temperature and the wash step was repeated three 
times. To each well, 100 µl of a 5 µg/ml antigen in PBS, pH 7.4 (appendix 6) was added and 
for the negative control, PBS without antigen was used. The plate was incubated in a sealed 
humidified container for 1 hour at room temperature. After incubation, the wells were washed 
50 
(3x) to remove excess antigen. Thereafter 100 µl of detection antibody, horseradish 
peroxidase-rabbit-IgG-anti-HSP (1:50 with 3% skimmed milk powder in phosphate buffered 
saline and 0.01% tween 20 (PBST)) (appendix 6) was added as a two-fold serial dilution. The 
plate was incubated in a sealed humidified container for 1 hour at room temperature.  The 
excess detection antibody was washed off three times with wash buffer and plate was blotted 
dry. To each well, 200 µl of chromogenic substrate (o-phenylenediamine dihydrochloride) was 
added and colour was allowed to develop at room temperature. The reaction was stopped by 
adding 50 µl of 3 M HCl to each well. Colour intensity was measured by an ELISA plate 
reader at 492 nm. 
 
3.13 Purification of vervet-anti-rabbit-IgG 
Vervet serum was purified by column ProSep A chromatography media (Millipore, USA) as 
described in 3.9, ‘Purification of IgG.’ 
 
3.14 Purification of goat-anti-rabbit-IgG 
Goat serum was purified as described previously (Kendall, 1938). A saturated ammonium 
sulphate ((NH4)2SO4) solution was prepared by dissolving 19 g of ammonium sulphate into 
25 ml of sterile distilled water. One and a half millilitre of the saturated ammonium sulphate 
solution was added to 3 ml of rabbit serum. This was followed by centrifugation for 
approximately 5 minutes at 5000 x g at 4oC. The supernatant was discarded and the 
precipitated proteins were dissolved in 1.5 ml of sterile distilled water to which 750 µl of 
saturated ammonium sulphate solution was added. This was then centrifuged (5000 x g, 4oC, 
5min) and the supernatant was discarded. This process was repeated five times. The pellet was 
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then dissolved in approximately 1.5 to 3 ml of PBS, pH 7.4 (appendix 6), depending on the 
size of the pellet, and the residual ammonium sulphate was removed by dialysis against PBS 
buffer, pH 7.4, overnight at 4oC. The following day, the contents of the tube was aliquoted 
into 100 µl volumes and stored at - 20oC until further use. 
 
3.15 Evaluation of the biological activity of purified antibody 
The biological activity of the purified IgG was measured as follows. Three wells of a 
microtitre plate were coated with purified vervet anti-rabbit antibodies (3.13) and purified goat 
anti-rabbit antibodies (3.14). The purified rabbit anti-HSP IgG was coated on three separate 
wells. The same rabbit IgG was conjugated with horseradish peroxidase and added to the first 
set of wells coated with vervet anti-rabbit antibodies and goat anti-rabbit antibodies. A 
commercially available conjugated goat anti-rabbit IgG ((Sigma-Aldrich, USA) was added to 
the rabbit anti-HSP coated wells. Following this, substrate was added to all of the coated wells 
and the reaction was stopped. ELISA procedure (blocking and washing) and incubation times 
used were the same as described in 3.10.1. Bovine serum albumin (BSA) was used as a 








Chapter Four: Results 
 
 4.1 Culture characteristics of Haemophilus ducreyi on solid media 





       
                                
 
Figure 4.1 a and b: Colony formation of H. ducreyi strain A54 on Modified Bieling (MB) agar at 48 hours.  
 
Colonies appeared to be small, non mucoid and grey in colour. These colonies are 
polymorphic in nature with some almost translucent in appearance and others opaque. When 




4.2 Gram stain 
Bacteria were Gram negative and appeared mainly as short rods, usually in clumps or in short 
chains. Figure 4.2 shows the characteristics of H. ducreyi commonly seen on solid agar which 
are described as whorls. This is in contrast to the streptobacillary form and the characteristic 
parallel chains described as ‘railroad tracks’ which are seen in Gram stains of liquid culture as 



















Figure 4.3 a, b and c: Gram stains of H. ducreyi from culture grown in Modified Bieling broth. 
 




4.3 Extraction, separation and purification of bacterial proteins 
H. ducreyi cells harvested from Bieling broth culture were lysed by sonication (3.3). Figure 
4.4 shows the SDS-PAGE gel electrophoresis of the lysed strains A54 and A68. 
 
 




Figure 4.4: SDS PAGE gel showing location of the heat shock protein from sonicate samples of H. ducreyi 
strains A54 and A68. 
 
Lanes 1, 2, 3 - sonicate preparation 1 (strain A54) – 20µ l, 10µ l and 5µ l, respectively;       
Lane 5, 6, 7 - sonicate preparation 2 (strain A54) – 20µ l, 10µ l and 5 µ l, respectively; 
Lane 8, 9, 10 - sonicate preparation 3 (strain A54) – 20µ l, 10µ l and 5µ l, respectively;  
Lane 12, 13, 14 - sonicate preparation 4 (strain A68) – 20µ l, 10µ l and 5µ l, respectively; 
Lane 4; 11: Marker - 116 – 14, 4 kDa; Lane 15: Marker - 205 – 6, 5 kDa  
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Strain A54 was analysed in triplicate. The profiles obtained were identical. Furthermore the 
protein profile of the sonicate sample of H. ducreyi strain A68 was comparable to the protein 
profile of sonicate samples of H. ducreyi strain A54. A large band of an approximate 
molecular weight of 60 kilodaltons (kDa) was found in each of the sonicates. This band was 
likely to represent the 58.5 kDa GroEL heat shock protein. 
 
The protein band of approximately 60 kDa was cut out of the gel and protein was eluted as 
described in 3.6. The protein solution obtained was again electrophoresed by means of SDS-





                     







Figure 4.5: SDS PAGE gel showing eluted 58.5 kDa GroEL heat shock protein by passive elution process. 
 
Lanes M: Protein marker, 20 kDa – 200 kDa;  
Lanes 1, 2, 3, 4 - gel eluted heat shock protein – 5 µl, 10 µl, 15 µl, 20 µl, respectively. 
          M         1             2            3            4         M 





The eluted protein was further purified by means of the ProteoSpin detergent clean-up kit and 




Figure 4.6: SDS PAGE gel showing the presence of the purified 58.5 kDa GroEL heat shock protein by 
means of the ProteoSpin kit. 
 
Lanes M: Protein marker, 20 kDa – 200 kDa;  
Lane 1: Purified heat shock protein 
 
4.4 Testing of rabbit serum for anti GroEL HSP antibodies 
The purified protein (3.7) was used to immunize the rabbits. Enzyme-linked immunosorbent 
assay (ELISA) methodology was used on rabbit sera to measure the results (3.10.1). A 96-well 
microtitre plate was coated with a serial dilution of the purified 58.5 kDa GroEL HSP 
providing the solid-phase antigen for the antibody detection system. Serum from each rabbit 




     Purified 58.5 kDa HSP 
 
 M         1                                                     M  
58 
reaction, optical density values were obtained at a wavelength of 492 nm (table 4.1, 4.2 and 
4.3). The results were used to construct a curve for the determination of the optimal coating 
concentration of antigen. This was done by taking the average of the 3 optical density readings 
per antigen dilution (9 µg/ml, 4.5 µg/ml, 2.25 µg/ml, 1.12 µg/ml, 0.56 µg/ml, 0.28 µg/ml, 0.14 
µg/ml, and 0.07 µg/ml). A curve was constructed for each rabbit by plotting the optical density 




























































Figure 4.7 Coating curve of Rabbit 1 for the determination of optimal antigen coating.  
 







    
  
































































Table 4.2: Absorbance readings from ELISA for Rabbit 2 
 












































































Figure 4.8: Coating curve of Rabbit 2 for the determination of optimal antigen coating.  
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Table 4.3: Absorbance readings from ELISA for Rabbit 3 
 

















































































Figure 4.10: Coating curves for Rabbits 1, 2 and 3 plotted together. 
 
Figure 4.10 shows the combined results. The coating curve with the serum of rabbit 1 (figure 
4.7) did not reach a plateau (maximum saturation of antigen by antibody) and therefore its 
optimal antigen coating has to be beyond 9 µg/ml. 
 
The coating curves with the sera of rabbit 2 (figure 4.8) and rabbit 3 (figure 4.9), followed a 
similar pattern and reached a plateau at 4.5 µg/ml. Based on these results, the antigen 
concentration chosen for antibody capture was 5 µg/ml.  
 
4.5 Immune response of the rabbits 
In order to evaluate the immune response of each rabbit and finally to select the rabbit with the 
highest antibody (Ab) titre, an ELISA (3.11) was performed on sera before and after 
immunization. The values obtained were used to determine the positive/negative (P/N) ratios for 
each rabbit.  
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Tables 4.4, 4.5 and 4.6 show the results. In each table, lanes A, B and C contain the ELISA 
readings after immunization while lanes D, E and F show the readings before immunization. 
The P/N value based on the calculated averages is shown in the bottom lane.  
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The difference between pre- and post-immunisation absorbance values of the serum of rabbit 2 
was significantly higher as compared to the other 2 rabbits and indicates that a strong immune 
response had occurred. This is reflected in the higher P/N value obtained with serum of rabbit 
2 as compared to the others. Therefore, this rabbit’s serum was used in the rest of the study. 
 
4.6 Purification of IgG antibodies 
The IgG fraction of the serum from rabbit 2 was purified by means of Protein A affinity 
chromatography. To show the level of purification the harvest was mixed with sample 
reducing buffer and subjected to SDS-PAGE. The resulting heavy (H) and the light (L) chains 
are shown in figure 4.11. 
 
 
                                   
 
Figure 4.11: SDS Page gel showing the presence of affinity purified IgG fractions of rabbit serum under 
reducing electrophoresis conditions. 
 
Lane M: Molecular marker, 20 kDa – 200 kDa; 
Lanes 1 – 6: sequential 1 ml fractions of purified IgG  






4.7 Determination of optimal capture and detection antibody concentration 
For the development of the antigen detection test, the capture antibody needs to be fixed to a 
solid phase while the detection antibody needs to be labelled. Since the chosen test system was 
ELISA (3.12), microtitre plates provided the solid phase while horseradish peroxidase was 
used as the label. The purified IgG fraction of rabbit 2 was used as capture as well as detection 
antibody. In order to determine the optimum concentration for capture and detection antibody, 
a checkerboard titration was performed with varying concentrations of both antibodies and a 
constant concentration of antigen (5 µg/ml). 
 
Table 4.7 shows the results of the checkerboard titration. The absorbance readings obtained 






Table 4.7: ELISA checkerboard titration to determine optimal capture and detection affinity purified antibody concentrations. 
  













































































































































































































































4.8 Evaluation of biological activity of purified antibody 
Since no antigen capture had occurred in the checkerboard titration (table 4.7) the biological 
activity of the purified IgG fraction which was used as capture antibody was evaluated. The 
results are shown in Table 4.8.  
 
The top panel shows that after coating, the capture antibody is present in the bottom of the 
wells. The ELISA readings after coating with BSA are significantly lower than after coating 
with the capture antibody. The bottom panel shows that the detection antibody is able to detect 
both vervet and goat anti-rabbit antibodies that were used for coating the wells.   
These experiments confirm that the raised rabbit antibodies do effectively coat the microtitre 
















Table 4.8: Evaluating biological activity of affinity purified antibody and labelled antibody 
 
Detection Antibody Capture Antibody  
(50 µg/ml) 
ELISA absorbance 

































































Chapter Five: Discussion 
 
This study is one of two that aimed at the development of an immuno-chromatography based 
test for the exclusion of chancroid and syphilis in patients with genital ulcer disease. This test 
was deemed essential to avoid treatment with anti-bacterial agents that are not needed now as 
chancroid and syphilis have almost disappeared in most settings.  
There are various approaches to the development of such a test. The study reported here is the 
first of these. This approach was not successful and therefore one of the other options needs 
now to be explored.  
 
The approach attempted here is based on the use of a secreted protein and a polyclonal 
purified IgG antibody to be used as capture as well as detection antibody. The 58.5 kDa HSP 
was chosen as the antigen. This was based on the fact that this protein is secreted by 
H. ducreyi in large amounts. Since the concentration of bacterial cells in ulcer secretions is 
low, the use of cell bound antigens was considered to be prone to fail.  
 
Microscopic characteristics and colony morphology of the H. ducreyi isolates used for antigen 
isolation was consistent with previous publications (Sturm and Zanen, 1984; Albritton, 1989; 
Morse, 1989). Since these were well characterized isolates, no further identification test were 
applied. 
 
Sodium dodecyl sulphate polyacrylamide gels were used to locate and separate the proteins 
from the bacterial sonicate sample. The protein of interest, the 58.5 kDa heat shock protein 
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was clearly visible as a large band which fell in the 60 kDa region, as described previously 
(Parsons et al, 1992; Brown et al, 1993). The abundance of the heat shock protein was 
confirmed by the large band with great intensity in comparison to other proteins found in the 
bacterial lysates. Others also found this HSP present intracellularly (Brown et al, 1993; 
Odhav, 1996; Frisk et al, 1998) as well as present in large amounts (Parsons et al, 1992; 
Brown et al, 1993). In this study, a large yield of the 58.5 kDa heat shock protein was obtained 
when the organism was harvested at its optimal growth temperature of 33oC. This was also 
observed by Brown et al (1993), when H. ducreyi cell lysate was analysed (Brown et al, 
1993).  
 
The two different Haemophilus ducreyi strains (A54 and A68) of sonicate samples tested had 
comparable protein profile patterns when screened on SDS PAGE gels and this remained 
consistent for all sonicate samples tested. In support of this, Lindquist and Craig (1988) had 
reported that heat shock proteins are a highly conserved group in prokaryotic organisms 
(Lindquist and Craig, 1988). 
 
Two approaches can be applied to obtain purified proteins: elution from gels after gel 
electrophoresis of lysates of H. ducreyi and cloning of the gene in a rapid and easy growing 
organism like an E. coli that is able to secrete the gene product in large amounts. 
We chose for the first, mainly since expertise with the cloning technique was not available. 
The method employed to passively elute polyacrylamide gel pieces (Nurhadi et al, 2003), was 
found to be a cost effective and rapid process.  However in order to gain a substantial amount 
of protein for the entire project, a large number of gels were required and therefore SDS 
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PAGE had to be done on a daily basis. This process was found to be laborious and time 
consuming.  
 
The ProteoSpin detergent kit was used to purify the protein eluted from the polyacrylamide gel 
pieces to effectively remove SDS present in the protein elution buffer, as well as the SDS 
particles that may have bound to the protein. This was necessary as purified protein free of 
SDS was required for downstream processes, such as the coating of ELISA plates. Even 
though the use of the kit was a rapid process and protein was concentrated in a smaller 
volume, a substantial amount of protein was lost, as the amount of protein measured prior to 
using the kit was found to be much higher than the final purified protein after the use of the 
kit. This loss of protein was attributed to the large dilution processes which were required for 
some of the purification steps as stipulated by the kit’s instruction insert. 
 
The immunoglobulin G (IgG) which was purified by means of Protein A affinity 
chromatography had to be passed through the affinity column twice as one passage was not 
sufficient to remove all of the contaminating proteins. This was evident when the purified IgG 
fraction was screened on SDS page gels. Even after two passages through the affinity 
purification column, a small amount of contaminating proteins was still observed. No further 
passages through the purification column were entertained since this can reduce biological 
activity and result in IgG denaturation as the elution buffer used had a very low pH.  
 
A good immune response was achieved with serum of one of the 3 rabbits immunized. This 
was before the purification process. However when the IgG fraction was purified as described 
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above no reaction was observed with the purified HSP. The control wells (PBS) exhibited 
similar values to those of the test wells. Even the immediate neutralization of the low pH of 
the IgG elution buffer by dialysis had resulted in no antibody activity being detected.  
 
The purified non-conjugated antibodies did still have capacity to coat the microtitre wells. 
Also, the purified conjugated antibody could be captured by the anti-rabbit IgG antibodies 
raised in 2 other animals. This indicates that the Fc portion was undamaged in the purification 
process. However, the antibodies were ineffective in capturing the HSP antigen. This can only 
be explained by the fact that the Fab portion had been made biologically inactive by the 
purification process.  
 
The problem with the low pH of the elution buffer is not uncommon, as Murphy et al (1986) 
had a similar experience. They were unable to detect IgG antibodies to P6 and indicated that 
their elution conditions (0.1 M glycine, pH 2.5) could have played a role in IgG antibody 
denaturation (Murphy et al, 1986). Akkoyunlu et al (1996) had reported on a loss of 
bactericidal activity against Haemophilus influenzae when affinity-isolated human anti-PDm 
antibodies which were eluted in an elution buffer of low pH were no longer found to be 
bactericidal (Akkoyunlu et al, 1996).  
 
In the current project, an attempt was made to overcome this problem by purifying the serum 
with a commercial antibody purification kit, PURE-1A (Sigma-Aldrich, USA). However when 
the final purified antibody fraction was screened on a SDS-PAGE gel under reducing 
conditions, it was found that a large amount of non-specific proteins were present and the 25 
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kDa light chain band and 50 kDa heavy chain band of IgG were not detectable. It did not make 
much difference when the same purified fraction underwent purification for a second time 
with the PURE-1A purification kit. These findings were reported to the manufacturer of the 
commercial antibody purification kit. In this project, the limiting factor was with an inefficient 
purification system and as Huse et al (2002) appropriately pointed out, “occasionally, a 
method recommended for the purification of a member of a antibody class, which should 
work, does not.” He goes on to state that these antibodies may not even bind or bind 
insufficiently during chromatography (Huse et al, 2002).  
 
A number of elution buffers are employed to recover proteins from affinity columns. The role 
of such an elution buffer is to break the chemical bonds involved in protein-protein interaction 
so that the target protein reverts back into its active form (Firer, 2001). When using affinity 
chromatography for purification, pH elution is the commonly used method to remove protein 
bound to ligands (Wikibooks). 
 
Antibody purification methods employ a change in the pH of the elution buffer  
(usually a low pH) which in some instances can result in significantly reduced antibody 
activity. Even though these harsh elution conditions may reduce antibody activity, the yield 
and purity of the antibody is usually good. This is different for milder elution conditions, 





Since the pH elution method is associated with a decrease in pH to elute bound protein 
(Wikibooks), it is advised to test various elution buffers on an affinity column before use 
(Huse, 2002); however this may have cost implications and be time consuming (Firer, 2001). 
 
In this study, a high affinity ligand, Protein-A was used which binds specifically to the Fc-
portion of the IgG molecule. Due to its high affinity, protein-A columns require denaturing 
conditions with extremely low pH for the elution of the IgG antibodies. This low pH results in 
conformational changes of the antibody, and this may cause antibody degradation and 
aggregation. The use of milder elution conditions could avoid this problem (Arakawa et al, 
2004). However when using a high affinity ligand like Protein-A, milder conditions may result 
in partial elution. In other words, it would be difficult to elute antibody with a milder pH 
elution buffer if it has a high affinity to the chromatography media being used.  
The requirement of stringent elution buffers for the use of high affinity interactions could 
result in partial denaturation and a decrease or loss of activity of the released target protein 
(Firer, 2001). 
 
Arakawa et al (2004) has demonstrated the use of arginine as an efficient eluent for the elution 
of antibodies when low pH elution buffers are utilized. Arginine seems to prevent protein 
aggregation during refolding; as observations showed that arginine does not affect the stability 
of native proteins and that the solubility of denatured proteins is increased (Arakawa et al, 
2004).  
 
Uptima mild elution medium is a non-denaturing elution medium which is also available for 
improved affinity purifications under neutral stabilizing conditions. This elution medium 
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firstly offers the advantage of increased antibody yields by 97% from immunoadsorbents 
without the loss of biological activity, and secondly preserves the antibody’s biological 
activity by 97%. Uptima mild elution medium is commercially available (Interchim, France).  
 
The use of Differential Scanning Calorimetry (DSC) is shown to be a promising method in 
making downstream purification processing of proteins more cost effective and reproducible 
in a robust way. A stability study conducted by Diosynth Biotechnology demonstrated that 
DSC maintained stability and protection of the molecule by means of stabilizing buffering 
elution conditions (Acharya, Diosynth Biotechnology-USA).   
 
Any of the methods described above could be used to purify antibody, as opposed to the use of 
a low pH elution buffer for the purification of antibody. However due to time constraints and 
the limited amount of antigen available for testing, the above mentioned methods for antibody 
purification analyses was not possible in this study. Even if the search for an effective elution 
process had been continued, the Protein-A affinity media used had showed a certain degree of 
affinity to non-specific antibodies, probably due to the hydrophobic properties of these non-
specific antibodies to the column, and hence further optimization would be required. Since the 
rabbit serum had been used up in the different experiments and the purified material was no 
longer active against the antigen of interest, we could no longer proceed to the development of 





Chapter Six: Conclusion 
 
This study attempted to develop a point-of-care test for the exclusion of chancroid in patients 
presenting with genital ulcer disease. The success of such an attempt depends on a number of 
things: the antigen, the use of purified naturally produced antigen versus antigen obtained after 
gene cloning and the use of polyclonal versus monoclonal antibodies. In this study, the use of 
naturally produced antigen and polyclonal antibodies for both antigen capture and detection 
was tried. This turned out not to be successful mainly because of problems with antibody 
purification which led to the loss of the Fab activity of the antibodies. This first attempt will be 
followed by the more demanding approach by the next student with antigen produced after 
gene cloning and monoclonal antibodies.  
 
In this project, the choice of using the same polyclonal antibody as both the capture and 
detection antibody against the 58.5 kDa heat shock protein could have limited the test to a 
certain extent. The potential of this test may be greatly improved by the use of a specific 
monoclonal antibody (MAb) against the 58.5 kDa heat shock protein as either capture or 
detection antibody, or the use of two polyclonal antibodies, where the capture and detection 







ACHARYA, P. Using differential scanning calorimetry to make downstream purification 
processing more economically viable: a case study. Analytical and Formulation Development 
Group at Diosynth Biotechnology, Research Triangle Park, NC. 
www.microcal.com/documents/DSC-downstream-purification.pdf 
 (Information accessed: 09 June 2009; 02:00 pm) 
 
AKKOYUNLU, M., JANSON, H., RUAN, M. & FORSGREN, A. (1996) Biological activity 
of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae. Infect 
Immun, 64, 4586-92. 
 
ALBRITTON, W. L. (1989) Biology of Haemophilus ducreyi. Microbiol Rev, 53, 377-89. 
 
ALFA, M. (2005) The laboratory diagnosis of Haemophilus ducreyi. Can J Infect Dis Med 
Microbiol, 16, 31-4. 
 
AL-TAWFIQ, J. A. & SPINOLA, S. M. (2002) Haemophilus ducreyi: clinical disease and 
pathogenesis. Curr Opin Infect Dis, 15, 43-7. 
 
ARAKAWA, T., PHILO, J. S., TSUMOTO, K., YUMIOKA, R. & EJIMA, D. (2004) Elution 




BAUER, M. E., GOHEEN, M. P., TOWNSEND, C. A. & SPINOLA, S. M. (2001) 
Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains 
extracellular throughout infection of human volunteers. Infect Immun, 69, 2549-57. 
 
BAUER, M. E. & SPINOLA, S. M. (2000) Localization of Haemophilus ducreyi at the 
pustular stage of disease in the human model of infection. Infect Immun, 68, 2309-14. 
 
BAUER, M. E., TOWNSEND, C. A., RONALD, A. R. & SPINOLA, S. M. (2006) 
Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. Microbes 
Infect, 8, 2465-8. 
 
BERGEY’S MANUAL OF SYSTEMATIC BACTERIOLOGY. (1984) Genus ? ? .    
Haemophilus. N. R. Krieg and J. G. Holt (ed.) ed. 
 
BONG, C. T., BAUER, M. E. & SPINOLA, S. M. (2002) Haemophilus ducreyi: clinical 
features, epidemiology, and prospects for disease control. Microbes Infect, 4, 1141-8. 
 
BOSU, W. K. (1999) Syndromic management of sexually transmitted diseases: is it rational or 
scientific? Trop Med Int Health, 4, 114-9. 
 
BROWN, T. J., JARDINE, J. & ISON, C. A. (1993) Antibodies directed against Haemophilus 




CARLONE, G. M., SCHALLA, W. O., MOSS, C. W., ASHLEY, D. L., FAST, D. M., 
HOLLER, J. S. & PLIKAYTIS, B. D. (1988) Haemophilus ducreyi Isoprenoid Quinone 
Content and Structure Determination. Int J Syst Bacteriol, 38, 249-253. 
 
CENTERS FOR DISEASES CONTROL AND PREVENTION. Sexually Transmitted Disease 
Surveillance Report- other STDs (1999). http://www.cdc.gov/std/stats99/ 
(Information accessed: 15 June 2006; 02:52 pm) 
  
CENTERS FOR DISEASES CONTROL AND PREVENTION. Sexually Transmitted Disease 
Surveillance (2008). http://www.cdc.gov/std/stats08/other.htm 
(Information accessed: 19 August 2010; 02:07 pm) 
 
CENTERS FOR DISEASE CONTROL AND PREVENTION. Sexually Transmitted Disease 
Treatment Guidelines (2006).  
 
CHEN, C. Y., MERTZ, K. J., SPINOLA, S. M. & MORSE, S. A. (1997) Comparison of 
enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of 
chancroid in the United States. J Infect Dis, 175, 1390-5. 
 
DANGOR, Y., RADEBE, F. & BALLARD, R. C. (1993) Transport media for Haemophilus 




ELKINS, C., YI, K., OLSEN, B., THOMAS, C., THOMAS, K. & MORSE, S. (2000) 
Development of a serological test for Haemophilus ducreyi for seroprevalence studies. J Clin 
Microbiol, 38, 1520-6. 
 
ERNST, A. A., MARVEZ-VALLS, E. & MARTIN, D. H. (1995) Incision and drainage versus 
aspiration of fluctuant buboes in the emergency department during an epidemic of chancroid. 
Sex Transm Dis, 22, 217-20. 
 
FINN, G. Y., KARIM, Q. N. & EASMON, C. S. (1990) The production and characterisation 
of rabbit antiserum and murine monoclonal antibodies to Haemophilus ducreyi. J Med 
Microbiol, 31, 219-24. 
 
FIRER, M. A. (2001) Efficient elution of functional proteins in affinity chromatography. J 
Biochem Biophys Methods, 49, 433-42. 
 
FRISK, A., ISON, C. A. & LAGERGARD, T. (1998) GroEL heat shock protein of 
Haemophilus ducreyi: association with cell surface and capacity to bind to eukaryotic cells. 
Infect Immun, 66, 1252-7. 
 
HAMMOND, G. W. (1996) A history of the detection of Haemophilus ducreyi, 1889-1979. 




HAMMOND, G. W., LIAN, C. J., WILT, J. C. & RONALD, A. R. (1978) Comparison of 
specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. J Clin 
Microbiol, 7, 39-43. 
 
HARKINS, K. R. (2001) Antibody Purification Methods. IN HOWARD, G. C. & BETHELL, 
D. R. (Eds.) Basic methods in antibody production and characterization. 
 
HAWKES, S., WEST, B., WILSON, S., WHITTLE, H. & MABEY, D. (1995) Asymptomatic 
carriage of Haemophilus ducreyi confirmed by the polymerase chain reaction. Genitourin 
Med, 71, 224-7. 
 
HUSE, K., BOHME, H. J. & SCHOLZ, G. H. (2002) Purification of antibodies by affinity 
chromatography. J Biochem Biophys Methods, 51, 217-31. 
 
INTERCHIM, FRANCE. Uptima Mild Elution Medium (document: FT-UP38591) 
http://www.interchim.com (Information accessed: 09 June 2009; 02:00 pm) 
 
JOHNSON, L. F., COETZEE, D. J. & DORRINGTON, R. E. (2005) Sentinel surveillance of 
sexually transmitted infections in South Africa: a review. Sex Transm Infect, 81, 287-93. 
 
KARIM, Q. N., FINN, G. Y., EASMON, C. S., DANGOR, Y., DANCE, D. A., NGEOW, Y. 
F. & BALLARD, R. C. (1989) Rapid detection of Haemophilus ducreyi in clinical and 
experimental infections using monoclonal antibody: a preliminary evaluation. Genitourin 
Med, 65, 361-5. 
 
83 
KENDALL, F. E. (1938) The use of immunochemical methods for the identification and 
determination of human serum proteins. Cold Spring Harbor Symposia on Quantitative 
Biology, 6, 376-384. 
 
LEWISa, D. A. (2000) Chancroid: from clinical practice to basic science. AIDS Patient Care 
STDS, 14, 19-36. 
 
LEWISb, D. A. (2000) Diagnostic tests for chancroid. Sex Transm Infect, 76, 137-41. 
 
LEWIS, D. A. (2003) Chancroid: clinical manifestations, diagnosis, and management. Sex 
Transm Infect, 79, 68-71. 
 
LEWIS, D. A. & ISON, C. A. (2006) Chancroid. Sex Transm Infect, 82 Suppl 4, iv19-20. 
 
LINDQUIST, S. & CRAIG, E. A. (1988) The heat-shock proteins. Annu Rev Genet, 22, 631-
77. 
 
MOHAMMED, T. T. & OLUMIDE, Y. M. (2008) Chancroid and human immunodeficiency 
virus infection--a review. Int J Dermatol, 47, 1-8. 
 




MUNSON, R. S. JR., RAY, W. C., MAHAIRAS, G., SABO, P., MUNGUR, R., JOHNSON, 
L., NGUYEN, D., WANG, J., FORST, C. & HOOD, L. (2003) The Complete Genome 
Sequence of Haemophilus ducreyi. http://www.ebi.ac.uk/cgi-bin/expasyfetch?AE017143 
(Information accessed: 22 May 2010; 02:08 pm) 
 
MURPHY, T. F., BARTOS, L. C., RICE, P. A., NELSON, M. B., DUDAS, K. C. & 
APICELLA, M. A. (1986) Identification of a 16,600-Dalton Outer Membrane Protein on 
Nontypeable Haemophilus influenzae as a Target for Human Serum Bactericidal Antibody. J  
Clin Invest, 78, 1020-1027. 
 
NATIONAL GUIDELINE FOR THE MANAGEMENT OF CHANCROID (2001). Clinical 
Effectiveness Group (Association for Genitourinary Medicine and the Medical Society for the 
Study of Venereal Diseases).  
http://www.spitalmures.ro/_files/protocoale_terapeutice/dermatologie%20venero/sancru%20
moale.pdf  (Information accessed: 29 January 2007; 03:08 pm) 
 
NURHADI, SIJAM, K. & SULAIMAN, I. (2003) Production of polyclonal antibody to the 
coat protein of Citrus Tristeza virus in chicken eggs. Indones J Agric Sci, 4, 18-26. 
 
ODHAV, B. (1996) Pathogenesis of Chancroid: Haemophilus ducreyi induced tissue damage. 
Department of Medical Microbiology. PhD Thesis, Durban, University of KwaZulu Natal.  
 
O'FARRELL, N. (2000) Chancroid in the United Kingdom. Sex Transm Infect, 76, 67-8. 
 
85 
ORLE, K. A., GATES, C. A., MARTIN, D. H., BODY, B. A. & WEISS, J. B. (1996) 
Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes 
simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol, 34, 49-54. 
 
PANTZAR, M., TENEBERG, S. & LAGERGARD, T. (2006) Binding of Haemophilus 
ducreyi to carbohydrate receptors is mediated by the 58.5-kDa GroEL heat shock protein. 
Microbes Infect, 8, 2452-8. 
 
PARSONS, L. M., SHAYEGANI, M., WARING, A. L. & BOPP, L. H. (1989) DNA probes 
for the identification of Haemophilus ducreyi. J Clin Microbiol, 27, 1441-5. 
 
PARSONS, L. M., WARING, A. L., OTIDO, J. & SHAYEGANI, M. (1995) Laboratory 
diagnosis of chancroid using species-specific primers from Haemophilus ducreyi groEL and 
the polymerase chain reaction. Diagn Microbiol Infect Dis, 23, 89-98. 
 
PARSONS, L. M., WARING, A. L. & SHAYEGANI, M. (1992) Molecular analysis of the 
Haemophilus ducreyi groE heat shock operon. Infect Immun, 60, 4111-8. 
 
PATTERSON, K., OLSEN, B., THOMAS, C., NORN, D., TAM, M. & ELKINS, C. (2002) 
Development of a rapid immunodiagnostic test for Haemophilus ducreyi. J Clin Microbiol, 40, 
3694-702. 
 
ROSEN, T., VANDERGRIFF, T. & HARTING, M. (2009) Antibiotic use in sexually 
transmissible diseases. Dermatol Clin, 27, 49-61. 
 
86 
ROSSAU, R., DUHAMEL, M., JANNES, G., DECOURT, J. L. & VAN HEUVERSWYN, H. 
(1991) The development of specific rRNA-derived oligonucleotide probes for Haemophilus 
ducreyi, the causative agent of chancroid. J Gen Microbiol, 137, 277-85. 
 
SCHMID, G. P. (1999) Treatment of chancroid, 1997. Clin Infect Dis, 28 Suppl 1, S14-20. 
 
SCHMID, G. P., FAUR, Y. C., VALU, J. A., SIKANDAR, S. A. & MCLAUGHLIN, M. M. 
(1995) Enhanced recovery of Haemophilus ducreyi from clinical specimens by incubation at 
33 versus 35 degrees C. J Clin Microbiol, 33, 3257-9. 
 
SOTTNEK, F. O., BIDDLE, J. W., KRAUS, S. J., WEAVER, R. E. & STEWART, J. A. 
(1980) Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin 
Microbiol, 12, 170-4. 
 
SPINOLA, S. M., BAUER, M. E. & MUNSON, R. S., JR. (2002) Immunopathogenesis of 
Haemophilus ducreyi infection (chancroid). Infect Immun, 70, 1667-76. 
 
STEEN, R. (2001) Eradicating chancroid. Bull World Health Organ, 79, 818-26. 
 
STURM, A. W. & ZANEN, H. C. (1984) Characteristics of Haemophilus ducreyi in culture. J 





TOTTEN, P. A., KUYPERS, J. M., CHEN, C. Y., ALFA, M. J., PARSONS, L. M., DUTRO, 
S. M., MORSE, S. A. & KIVIAT, N. B. (2000) Etiology of genital ulcer disease in Dakar, 
Senegal, and comparison of PCR and serologic assays for detection of Haemophilus ducreyi. J 
Clin Microbiol, 38, 268-73. 
 
TREES, D. L. & MORSE, S. A. (1995) Chancroid and Haemophilus ducreyi: an update. Clin 
Microbiol Rev, 8, 357-75. 
 
UK NATIONAL GUIDELINE FOR THE MANAGEMENT OF CHANCROID (2007). 
Clinical Effectiveness Group (British Association for Sexual Health and HIV, BASSH). 
http://www.bashh.org/documents/85/85.pdf  
(Information accessed: 08 February 2008; 12:50 pm) 
 
VUYLSTEKE, B. (2004) Current status of syndromic management of sexually transmitted 
infections in developing countries. Sex Transm Infect, 80, 333-334. 
 
WIKIBOOKS. Structural biochemistry/proteins/purification/affinity chromatography. 
http://en.wikibooks.org/wiki/Structural_Biochemistry/Proteins/Purification/Affinity 
chromatography (Information accessed: 19 May 2010; 05:02 pm). 
 
WORLD HEALTH ORGANISATION. Guidelines for the Management of Sexually 




WU, J. J., HUANG, D. B., PANG, K. R. & TYRING, S. K. (2004) Selected sexually 







Appendix 1: Media used to culture H. ducreyi 
 
A. Preparation of Modified Bieling Broth 
To make up 300 millilitres of Modified Bieling broth, you would require: 
- 50 ml horse blood 
- 50 ml dH2O 
- 200 ml Columbia broth (autoclaved) 
- 2 % (6 ml) IsoVitalex 
Combine the 50 ml of horse blood with 50 ml of dH2O in a sterile glass bottle. Set aside for 30 
minutes to allow for lyses of blood. Once blood is lysed, add this to the 200 ml of Columbia 
broth followed by 2% (6 ml) of IsoVitalex. Mix well. 
Aliquot the broth into smaller quantities as required and store at room temperature. 
 
B. Preparation of Modified Bieling Agar  
To make up 1 litre of Modified Bieling agar, you would require: 
- 165 ml horse blood 
- 165 ml dH2O 
- 24.6 g Columbia agar base 
- 650 ml dH2O 
- 20 ml IsoVitalex 
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Combine the 165 ml of horse blood with the 165 ml of dH2O in a sterile glass bottle. Set aside 
for 30 minutes to allow for lyses of horse blood. 
Combine the 24.6 g Columbia agar base with the 650 ml dH2O, mix well and autoclave. When 
the Columbia agar base mixture is warm, add the lysed horse blood followed by the 20 ml 
IsoVitalex. Mix well and aliquot the mixtures at 20 ml per Petri dish to make up 50 Modified 
Bieling agar plates. 
  
C. Storage media for H. ducreyi 
To make up 100 ml of storage media, you would require: 
- 1 g Protease Peptone No3 
- 90 ml dH2O 
- 10 ml Glycerol 
Dissolve 1 g protease peptone No3 in 90 ml of  dH2O. To this add 10 ml of glycerol and mix 












Appendix 2: Gram stain procedure 
 
A glass slide was prepared with a culture smear and subjected to the following: 
- Slide was heat fixed and flooded with crystal violet for one minute. Excess dye was 
washed off gently with tap water.  
- Slide was then flooded with iodine for one minute, after which excess iodine was removed 
over a sink and washed with acetone for a few seconds. Excess acetone was washed off 
with water. 
- Slide was then flooded with carbol fuchsin for 30 seconds and then rinsed with water. 















Appendix 3: Preparation of SDS PAGE solutions 
 
A. Acrylamide/Bis solution  
-    29 g Acrylamide (Biorad) 
-    0.8 g Bis-methylene-acrylamide (Biorad) 
Add the above to 100 ml dH2O. Filter and store at 4oC in the dark (30 days maximum use). 
 
B. Separating or resolving buffer (1.5 M Tris-HCL, pH 8.8) 
- 18.15 g Tris base 
Add the above to 50 ml dH2O and adjust pH to 8.8 with 1N HCL. Bring volume to 100 ml 
with dH2O and store at 4oC. 
 
C. Stacking buffer (0.5 M Tris-HCL, pH 6.8) 
- 6 g Tris base 
Add the above to 60 ml dH2O and adjust pH to 6.8 with 1N HCL. Bring volume to 100 ml 
with dH2O and store at 4oC. 
 
D. 10% SDS 
- 10g SDS 






E. Ammonium persulphate (10%) (APS) 
- 0.1 g Ammonium persulphate  
Dissolve 0.1 g APS in 1ml of dH2O. 
 
F. Sample reducing buffer  
- 2  ml 20% SDS 
- 2.5 ml 0.5 M Tris-HCl, pH 6.8 
- 1 ml b-mercaptoethanol 
- 2.5 ml Glycerol 
Mix the above reagents together and add a small amount of bromophenol blue dye powder to 
obtain a dark blue colour. 
 
G. Fixing solution 
- 250 Isopropanol 
- 100 ml Acetic acid 
Mix the above reagents and bring volume to 1 litre with dH2O. 
 
H. Coomassie staining solution 
- 1 g Coomassie blue 
- 500 ml (50%) Methanol 
- 100 ml (10%) Acetic acid 





I. Destaining solution 1 
- 500 ml (50%) Methanol 
- 100 ml (10%) Acetic acid 
Mix the above reagents and bring volume to 1 litre with dH2O. 
 
J. Destaining solution 2 
- 70 ml (7%) Methanol 
- 100 ml (10%) Acetic acid 
Mix the above reagents and bring volume to 1 litre with dH2O. 
 
K. 10 X Electrode buffer 
- 3.028 g Tris base 
- 1 4.413 g Glycine 
- 1 g SDS  








Appendix 4: Gel preparation for SDS-PAGE slab 
 
Table 8.1: Separating gel preparation - 12% for SDS-PAGE 






   3.35 ml 
 









































Table 8.2: Stacking gel preparation - 4% for SDS PAGE 
 

















































Appendix 5: Preparation of protein elution buffer and IgG elution buffer 
 
A. Protein elution buffer 
- 0.25 M Tris-HCL, pH 6.8 
- 0.1% SDS 
Make up a solution of 0.25 M Tris-HCL, pH 6.8 and add 0.1% SDS.  
 
B. IgG elution buffer 
-   0.1 M Glycine (7.5 g) 





Appendix 6: ELISA solutions 
 
A. ELISA Coating buffer (Bicarbonate buffer) 
- 5.3 g Sodium Carbonate (Na2CO3) 
- 4.2 g Sodium Hydrogen Carbonate (NaHCO3) 
Dissolve 5.3 g of Na2CO3 in 900 ml dH2O. To this solution dissolve 4.2 g of NaHCO3 and pH 
to 9.6. Adjust volume to 1 litre with additional dH2O and store at 4oC 
 
B. ELISA Blocking buffer (3%) 
- 5.3 g Sodium Carbonate (Na2CO3) 
- 4.2 g Sodium Hydrogen Carbonate (NaHCO3) 
Dissolve 5.3 g of Na2CO3 in 900 ml dH2O. To this solution add 4.2 g of NaHCO3 and pH to 
9.6. Dissolve the 30 g of non-fat dry milk to the above solution and adjust the volume to 1 litre 
with additional dH2O. Make up blocking buffer daily when required. 
 
C. Phosphate buffered saline – PBS 
To make up 1 litre of PBS, the following is required: 
- 8g NaCl 
- 0.2 g KCl 
- 1.44 g Na2HPO4 
- 0.24 g KH2PO4 
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Dissolve the above reagents in 800 ml dH2O and adjust pH to 7.4. Bring volume to 1 litre and 
autoclave. Store at 4oC. Alternatively 1 PBS tablet can be dissolved in 100 ml dH2O, 
autoclaved and stored at 4oC. 
 
D. ELISA Wash buffer (1X Phosphate buffered saline tween-20-PBST) 
For every 100 ml of 1x PBS add 10 µl (0.01%) tween-20 to make up 100 ml ELISA wash 
buffer. 
 
E. ELISA Detection antibody diluent for IgG-HRP conjugate  
- 3 g  
- Skimmed milk powder 
- 100 ml PBST 












Appendix 7: Horseradish peroxidase conjugation and reagent preparation 
 
A. Conjugation preparation 
1. Equilibrate a column (1.4 x 5cm) of Sephadex G-25 with 30 ml of 1 mM Sodium 
acetate buffer, pH 4. 
2. Dissolve 8 mg Horseradish Peroxidase (HRP) in 1 ml of distilled water and leave 
aside. 
3. Add 50 µl of 0.2 M NaIO4 freshly dissolved in distilled water and vortex. (The mixture 
should immediately turn green). Let the above activation mixture stand for 20 minutes 
at room temperature. 
4. Remove the excess NaIO4 from the activation mixture by desalting on the Sephadex G-
25 column. 
5. Add the prepared HRP to the column and allow for activated HRP to drip directly onto 
a continuously vortexed test tube containing 16 mg of antibody (previously dialysed 
against NaHCO3 buffer, pH 9.5, overnight). 
6. Let conjugated antibody stand for 4 hours at room temperature, after which add an 
equal volume of conjugate stabiliser buffer to the prepared HRP-antibody conjugate 
and store in refrigerator. 
 
B. Conjugate stabiliser buffer 
-    Glyerol 
-    20% Human serum albumin 
-   Tris-saline buffer, pH 8.0 
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Mix 50 ml glycerol with 49 ml tris-saline buffer, pH8.0. Add 1 ml 20% human serum albumin 
and stir on a magnetic stirrer until well mixed. Add mixture to a suitable container and store in 
refrigerator. 
 
